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Abstract 
 
 
Changing Landscapes: Perspectives of Young African American Women of Population-Wide 
Testing for Hereditary Breast Cancer Mutations 
 
 
By Alesha Henderson, MA  
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Philosophy at Virginia Commonwealth University. 
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INTRODUCTION: Young African American women continue to die from breast cancer at 
higher rates than White women. In an effort to promote breast cancer prevention, population-
wide testing (PWT) for all women in the U.S. starting at age 30 is a potential future initiative that 
is garnering a lot of attention. The decreasing cost of genetic testing may make this a possible 
reality in the future. However, African American women currently utilize genetic testing for 
hereditary breast cancer at lower rates than White women. Therefore, if young African American 
women are not prioritized in a future roll out of PWT, then existing breast cancer and genetic 
testing disparities will likely continue to widen. 
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PURPOSE: The purpose of this dissertation was to conduct a sequential exploratory mixed 
methods study to understand young African American women’s (18-30 years) perspectives 
towards hereditary breast cancer mutations, direct to consumer testing, PWT, as well as health 
communication preferences. This study also aimed to explore the factors that influence intentions 
to participate in such a service in the future.  
 
METHODS: Seven focus groups were conducted with 39 young women residing in a southern 
community and attending two local universities. A\thematic analysis was conducted using 
MAXQDA qualitative software to identify themes and subthemes. A survey was developed 
based upon focus group findings and tested using two rounds of cognitive interviews (n=10). The 
survey was distributed via Qualtrics Online Sample (n=170) to examine the factors that influence 
intentions to participate in PWT. Simple and multiple regressions were conducted to understand 
which factors were significantly associated with intentions.  
 
RESULTS: Focus group participants had limited to no knowledge about hereditary breast cancer 
mutations. Participants indicated that it was important for PWT to be accessible to everyone, 
normalized in American society, and to be thoroughly researched before it is presented as a 
viable option to the general public. Motivators to participate in PWT included having a family 
history of breast cancer, access to equitable healthcare quality, and concerns for future off-
spring. Barriers to intended participation in PWT included medical mistrust and concerns about 
affordability. Moreover, survey findings indicated that participants had moderate knowledge of 
hereditary breast cancer mutations and moderate levels of medical mistrust. Separate unadjusted 
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and adjusted multiple regressions indicated that both subjective norms and motivators to 
participate in direct to consumer testing remained significant predictors of intentions to 
participate in PWT after accounting for sociodemographic variables.  
 
CONCLUSION: This was the first study to preemptively explore young African American 
women’s perspectives and intentions to participate in future PWT.  As discussions continue 
about the potential for this new service, it will be imperative for researchers and public health 
practitioners to prioritize the needs and preferences of young African American women when 
designing interventions and potential health promotion strategies. This study findings provide 
potential avenues for future research, public health programming, trainings, and public 
campaigns in this area.  
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Chapter 1: Introduction 
Background  
African American women are more likely to die from breast cancer than any other racial 
group (Desantis et al. 2019).  Despite White women having the highest incidence of breast 
cancer, African American women are most likely to be diagnosed at earlier ages, later stages, and 
more likely to be diagnosed with triple negative breast cancer that lacks proper treatment and is 
associated with the presence of a hereditary breast cancer mutation. This disparity worsens when 
examining young African American women (>40 years). Young African American women, who 
are younger than the recommended mammography screening age, not only have the highest 
incidence and mortality rates of breast cancer but are also most likely to be diagnosed with triple 
negative breast cancer. Studies have also consistently found a high rate of hereditary breast 
cancer mutations amongst young African American women breast cancer survivors but that 
African American women tend to utilize genetic counseling and testing for hereditary breast 
cancer mutations at lower rates than White women (Armstrong, Micco, Carney, Stopfer, & Putt, 
2005; Jones et al., 2016; Pal et al., 2015). To promote breast cancer prevention amongst all 
women in the United States, population-wide testing (PWT) for hereditary breast cancer 
mutations is being proposed for all women starting at age 30. However, given the current low 
participation rates of African American women in genetic counseling and testing for hereditary 
breast cancer mutations, the benefits of such a proposed initiative may not reach this group and 
in turn only widen existing breast cancer disparities.  Understanding young African American 
women’s perspectives and intentions to participate in PWT for hereditary breast cancer 
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mutations, may help to design interventions and health promotion programming to ultimately 
increase participation in this potential new service.  
Genetic Counseling and Testing and African American women  
Genetic counseling and testing (GCT) for hereditary breast cancer mutations could 
provide a unique pathway to prevention and treatment of breast cancer among African American 
women (Force, 2019). Current statistics estimate that the breast cancer gene 1 and breast cancer 
gene 2 (BRCA1/2) account for between 5-10 percent of all breast cancers (Force, 2019). Genetic 
testing for BRCA1/2 was recently expanded to multi-gene panel testing to account for other 
hereditary breast cancer genes, including PALB2, ATM, TP53, PTEN and a host of others 
(Afghahi & Kurian, 2017). These additional genes are said to account for between 5 and 6 
percent of all breast cancers (Afghahi & Kurian, 2017).  Given that African American women 
utilize genetic counseling and testing at lower rates than White women (Armstrong et al., 2005; 
Jones et al., 2019; McCarthy et al., 2016), researchers know considerably less about the 
prevalence of hereditary breast cancer mutations in this group.  Malone et al. found that 4% of all 
breast cancers amongst African Americans had a BRCA1/2 mutation present (Malone et al., 
2006). Pal et al. found that 20% of African American women with triple negative breast cancer 
in the study sample had a BRCA1/2 mutation and that those diagnosed with triple negative breast 
cancer at younger ages had an even higher percentage of BRCA1/2 mutations (Pal et al., 2015). 
Further, they found that 22 percent of African American women under the age of 35 had a 
BRCA1/2 mutation (Pal et al., 2015). When examining rates in multi-gene panel testing, Churpek 
et al. (2015) found that among the 65 African American women in their sample with a hereditary 
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breast cancer mutation, the sample consisted of 57 different types of hereditary breast cancer 
mutations (Churpek et al., 2015). Further, 20 percent of African American women with a 
hereditary breast cancer mutation were carriers of non-BRCA 1/2 genes from the multi-gene 
panel test (Churpek et al., 2015). These study findings point to the potential interconnectedness 
of some African American women’s experiences with breast cancer and the presence of 
hereditary breast cancer mutations as well as the need to ensure that this group also reaps the 
benefits of PWT for hereditary breast cancer mutations.  
 The presence of hereditary breast cancer mutations in African American women is of 
concern because mutation carriers have an elevated risk (40-80%) of developing breast cancer 
over their lifetime (Institute, 2018 ; Petrucelli, Daly, & Feldman, 2010),  compared to the 
average risk of 12% (DeSantis, Ma, Goding, Newman, & Jemal, 2017; Institute, 2018 ; Petrucelli 
et al., 2010). These mutations are hereditary in nature and are passed down from one family 
member to another (Petrucelli et al., 2010). The risk of having a hereditary breast cancer 
mutation among children and siblings of a mutation carrier is 50%, while nieces and nephews of 
a mutation carrier have a hereditary breast cancer mutation risk of 25% (Petrucelli et al., 2010). 
Getting tested not only has implications for understanding their own risks for breast cancer but 
also that of their families. Current recommendations from the National Comprehensive Cancer 
Network advise women who have a family history of breast cancer that is suggestive of a 
hereditary breast cancer mutation to undergo genetic counseling and testing beginning at 18 
years old (NCCN, 2018). Several prevention strategies are available to women who find out that 
they are hereditary breast cancer mutation carriers, including preventive double mastectomy, 
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chemoprevention, and more frequent screening schedules than women who are not carriers 
(Force, 2019).  
Barriers and Motivators to Genetic Counseling and Testing for African American women 
Most extant research has focused on the perspectives and knowledge levels around 
hereditary breast cancer of African American women (<40) with a family or personal history of 
breast cancer suggestive of a hereditary breast cancer mutation (Adams, Christopher, Williams, 
& Sheppard, 2015; Hughes, Fasaye, Lasalle, & Finch, 2003; Kessler et al., 2005; Sheppard et al., 
2014; Sheppard, Mays, Tercyak, & LaVeist, 2013). Prior studies have indicated that lack of 
knowledge, high cost of testing, medical mistrust, limited access to healthcare, perceived familial 
approval of testing, and lack of physician recommendation are all barriers to the utilization of 
genetic counseling and testing services (Adams et al., 2015; McCarthy et al., 2016; Sheppard et 
al., 2014; Sheppard et al., 2013; Thompson et al., 2012).  For example, Sheppard et al. 2014 
found that African American women at high risk for hereditary breast cancer mutations were 
worried about how their genetic data would be stored and used against them in the future, 
potential high cost of testing, as well as issues surrounding access to healthcare services 
(Sheppard et al., 2014). African American women at high risk for breast cancer listed motivators 
to participate in genetic counseling and testing including, the potential benefit of disclosing their 
status to family members so that they can also be aware of their future breast cancer risk, the 
ability to have the counseling and testing covered by insurance, and the ability to help other 
individuals in the Black community (Sheppard et al., 2014).  
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Studies focusing on the perspectives of African American women without a family or 
personal history of breast cancer have been limited.  Adams et al. (2015) employed intercept 
interviews with African American women without a family history suggestive of hereditary 
breast cancer at public places in Washington, D.C. to understand perspectives of hereditary 
breast cancer mutations (Adams et al., 2015). Study participants mentioned similar advantages 
and disadvantages of hereditary breast cancer mutations as African American women at high risk 
for the mutations including, cancer prevention and the ability to inform family members of their 
breast cancer risk, medical mistrust, and potential emotional distress caused by knowing their 
status  (Adams et al., 2015). However, many of the women indicated that they would participate 
in testing if offered to them (Adams et al., 2015). Currently, there is only one study that includes 
African American women’s perspectives about and perceived acceptability of PWT but the mean 
age of participants was 37.7 years (Rubinsak et al., 2019).  If PWT is implemented in the future, 
it will be imperative to understand whether African American women approaching the proposed 
screening age (18-30) for PWT mirror those of older African American women.  
The Push for Population-wide testing  
 In 2014, the founder of hereditary breast cancer mutations, Mary-Claire King, and 
colleagues called for PWT for BRCA1/2 mutations for all women regardless of their family 
history of breast cancer beginning at age 30. The call for PWT was prompted by a study that 
indicated that up to 50 percent of hereditary breast cancer mutations are missed with current 
screening criteria (King, Levy-Lahad, & Lahad, 2014) . Furthermore, King et al. 2014 expressed 
concerns about genetic counseling and testing not being used until after a woman has been 
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diagnosed with breast cancer instead of being used as a form of breast cancer prevention (King et 
al., 2014).  Furthermore, making the switch to PWT would eliminate the current model that 
hinges on physicians as gatekeepers to genetic counseling and testing for the mutations. Prior 
research has shown that physicians lack knowledge about genetic counseling and testing for 
hereditary breast cancer mutations. Moreover, Bellcross et al. 2011 found that less than 20 
percent of primary care physicians knew all of the increased-risk for hereditary breast cancer 
mutations scenarios provided in the study (Bellcross et al., 2011). The elimination of the need for 
physician recommendation for genetic counseling and testing could be beneficial to all women 
but could be transformative for breast cancer prevention amongst African American women 
given that formative research has consistently indicated that lack of physician recommendation is 
a major barrier to participation in genetic counseling and testing.  
As can be expected of any new preventive service, there are several oppositions to PWT. 
Opponents, of PWT argue that it is hard to justify implementing PWT in more diverse and larger 
populations, such as the United States, that may prove to not be cost effective based upon current 
BRCA1/2 risk estimates (Foulkes, Knoppers, & Turnbull, 2016; Long & Ganz, 2015). 
Furthermore, the research supporting PWT is largely based upon studies with Ashkenazi Jews, 
who are known to have a high prevalence of hereditary breast cancer mutations (Foulkes et al., 
2016). Therefore, given that the United States has a more diverse population, there will also be 
increased risk for false positives as well as the identification of variants of unknown significance 
that cause unnecessary psychological distress, especially in minority populations (Foulkes et al., 
2016; Yurgelun, Hiller, & Garber, 2015). Despite the challenges to implementation of PWT, 
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recent studies indicating the cost-effectiveness of PWT and the acceptability of this initiative to 
women provide strong support for this initiative to become a reality in the future (Manchanda & 
Gaba, 2018; Rubinsak et al., 2019). Given the potential challenges of implementing PWT as it 
relates to minority populations, it is important to proactively understand the potential challenges 
and barriers that may impact African American women’s uptake of PWT.  
Potential Population-wide testing and Young African American women  
African American women from the millennial generation are an important target 
population for this study given that, if implemented, PWT would begin at 30 years for all women 
in the United States. The perspectives of younger African American women, who are 
approaching the proposed screening age for PWT, are important because they are approaching 
eligibility to use this service as a pathway to breast cancer prevention if PWT was to be 
implemented. African American women are disproportionately impacted by the breast cancer 
disparity and currently utilize genetic counseling and testing for hereditary breast cancer 
mutations at lower rates than White women, therefore it is imperative that researchers 
preemptively gather the perspectives of young African American women towards PWT. Their 
perspectives would provide insights into recommendations for public health practitioners at both 
local and state health departments to reach and raise awareness in this group around PWT for 
hereditary breast cancer mutations. Moreover, their participation in counseling and testing could 
provide a better understanding of variants of unknown significance found in this population. 
Some may argue that capturing this population’s perspectives would be premature since this is 
still an ongoing debate but it is critical that we preemptively explore the perspectives and needs 
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of populations that are underrepresented in genetic counseling and testing services as well as 
those that are disproportionately impacted by breast cancer when thinking about rolling out 
PWT. If the tides do shift towards PWT for hereditary breast cancer mutations in the United 
States, disparities in both breast cancer and genetic counseling and testing utilization among 
younger African American women will continue if we do not proactively seek out their 
perspectives of this potential shift. 
Younger African American women’s perspectives towards genetic counseling and testing 
for hereditary breast cancer mutations may be vastly different from older African American 
women, given that they have been exposed to the proliferation of direct to consumer genetic 
services that provide information about the connection between their genes and health to their 
front door without the need for a physician recommendation (Bowen & Khoury, 2018; Estrada, 
2017). The millennial generation of African American women born between 1982 and 2004 
came of age during the technology revolution and most recently during the rise of direct to 
consumer genetic testing used to provide answers about ancestry and health. Direct to consumer 
genetic testing services (DTC testing), such as Ancestry.com and 23andMe, are steadily 
increasing in popularity in the United States (Bowen & Khoury, 2018). To date, there have been 
a limited number of studies that provide insight into DTC testing uptake and the perspectives of 
racial minorities on DTC testing (Bloss et al., 2010; Carroll et al., 2019; Hensley Alford et al., 
2011; Landry et al., 2017). Studies have found that African Americans use DTC testing at similar 
rates as Whites and are more interested in using these services to learn about ancestry than 
disease information (Carroll et al., 2019; Landry et al., 2017). However, none have focused 
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specifically on young African American women’s perspectives of DTC testing services. There 
are distinct differences between DTC testing and population-wide testing in that DTC testing is 
largely handled by private companies whereas PWT would be implemented by the healthcare 
system.  Despite these differences, young African American women’s perspectives on an already 
widely available genetic counseling and testing service, such as DTC testing, could provide 
further insight into their perspectives about PWT in the future.  
Research Aims and Hypotheses  
To date, few, if any studies have focused on the knowledge gaps and perspectives of 
African American women (18-30 years) from the millennial generation towards hereditary breast 
cancer mutations and PWT for hereditary breast cancer mutations. Given the current proposal for 
PWT for hereditary breast cancer mutations, it is imperative that as researchers preemptively 
assess the needs and perspectives of young African American women given the known breast 
cancer disparity. Therefore, the purpose of this dissertation is to conduct a sequential exploratory 
mixed methods study to understand young African American women’s perspectives towards 
hereditary breast cancer mutations, PWT, DTC testing, and health communication preferences if 
PWT became available in the future. This study also aims to understand the factors that impact 
intentions to participate in PWT for hereditary breast cancer mutations in the future.  The 
specific aims research aims and hypotheses are as follows: 
 
Aim 1:  Identify knowledge gaps and attitudes (perceived disadvantages, advantages, subjective 
norms, medical mistrust) towards genetic counseling for hereditary breast cancer mutations, 
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motivators and barriers to participating in PWT for hereditary breast cancer mutations, health 
communication preferences for PWT for hereditary breast cancer mutations  among African 
American women aged 18-30 years old, and  perspectives about DTC genetic testing services.  
Aim 1 Approach: African American women between the ages of 18 and 30 will be 
recruited from Virginia Commonwealth University, Virginia Union University, and the 
Greater Richmond area to participate in six focus groups (N~40) about knowledge and 
perspectives of hereditary breast cancer mutations, willingness to participate in PWT, 
health communication preferences for PWT, as well as perspectives about DTC genetic 
testing services. 
Aim 2: Examines the factors that influence young African American women’s intentions to 
participate in PWT for hereditary breast cancer mutations.   
Aim 2 Approach: African American women between the ages of 18 and 30 (N~ 160) 
will be recruited using Qualtrics Online Sample to complete a survey about their 
knowledge and perspectives of genetic counseling and testing for hereditary breast cancer 
mutations, intentions to participate in PWT for hereditary breast cancer mutations, health 
communication preferences, as well as perspectives about DTC genetic testing services. 
Hypothesis 1:  Participants will have low levels of knowledge about hereditary breast 
cancer mutations and low levels of medical mistrust. 
Hypothesis 2: There will be a positive relationship between participants’ attitudes 
towards DTC testing and intentions to participate in PWT.    
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Hypothesis 3: There will be a positive relationship between participants’ subjective 
norms and intentions to participate in PWT. 
Hypothesis 4:  There will be a negative relationship between participants’ individual 
medical mistrust and intentions to participate in PWT.  
Hypothesis 5:  There will be a negative relationship between participants’ group-based 
medical mistrust and intentions to participate in PWT.  
Hypothesis 6:  There will be a positive relationship between participants’ perspectives 
towards hereditary breast cancer mutations and intentions to participate in PWT.  
Hypothesis 7:  There will be a positive relationship between perceived risk of hereditary 
breast cancer mutations and intentions to participate in PWT. 
Hypothesis 8: There will be a negative relationship between participants’ perceived 
severity of breast cancer and intentions to participate in potential population-wide testing.  
 
Dissertation format 
This aims of this study are presented in a three-paper format. All the papers provide an 
understanding of the literature relevant to the aim, methods used, as well as a results and 
discussion section.  
(Aim 1): The first paper (Chapter 2) presents findings from the qualitative analysis of 
focus groups with young African American women (students and community residents) that 
aimed to explore their perspectives towards PWT in the U.S.  
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(Aim 2): The second paper (Chapter 3) provides insight into the factors that would impact 
young African American women’s intentions to participate in PWT if offered in the future. 
These findings were gathered through a quantitative analysis of an online survey distributed 
through the Qualtrics Online Sample. 
(Aim 3): The third paper (Chapter 4) utilizes health communication related findings from 
Chapters 2 and 3 to create a data brief. The data brief, “Population-wide testing for Hereditary 
Breast Cancer Genes: Recommendations for Public Health Practitioners to Reach and Raise 
Awareness Amongst Young African American Women,” presents programming, training, and 
public health campaign recommendations that public health practitioners at health departments 
can use to best target and raise knowledge around PWT amongst young African American 
women (18-30 years). The chapter provides and overview that presents the importance of closing 
the translation gap between research and practice as well as the rationale for the brief.  While 
other chapters of this dissertation will be submitted to traditional academic journals, this brief 
will be provided to key stakeholders at the Virginia Department of Health. It will also be 
disseminated via Facebook through the Black Ladies in Public Health private Facebook group 
that consists of over 10,000 public health practitioners.  
The final chapter (Chapter 5) synthesizes the study findings as well as provides 
implications for future research and practice.  
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Chapter 2 
 
Paper 1 
Young African American women’s perspectives of the potential shift towards population-wide 
testing for hereditary breast cancer mutations: “We can do it, but just don’t take from us.” 
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Abstract  
 
Young African American women (<50 years) are twice as likely than their White counterparts to 
die from breast cancer. To promote breast cancer prevention, population-wide testing for 
hereditary breast cancer mutations was proposed for women in the U.S. starting at age 30. 
However, African American women currently utilize genetic testing for hereditary breast cancer 
at lower rates than White women. The purpose of this study is to examine the perspectives of 
African American women ages 18-30 towards population-wide testing for hereditary breast 
cancer mutations with the goal of understanding how to prevent the current utilization gap from 
widening if the new testing guidelines are adopted and to inform future health promotion 
campaigns. We conducted seven focus groups with 39 young women residing in a southern 
community and attending two local universities. Data was analyzed using a thematic analysis 
approach.  Findings indicate participants had limited knowledge of hereditary breast cancer 
mutations but asserted that it was important for population-wide testing to be accessible to 
everyone, normalized in American society, and to be thoroughly researched before it is presented 
as a viable option to the general public. Motivators to participate in population-wide testing 
included having a family history of breast cancer, access to equitable healthcare quality, and 
concerns for future offspring. Barriers to intended participation in population-wide testing 
included medical mistrust and concerns about affordability.  Future health promotion campaigns 
and research should determine how to normalize population-wide testing and increase 
geographic and economic accessibility for young African American women 
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Introduction 
African American women continue to die from breast cancer at a higher rate than White 
women. They are more likely to be diagnosed at earlier ages, with more advanced stages, and 
with triple- negative breast cancer which is a highly aggressive form of the disease that lacks 
targeted treatment (DeSantis et al., 2016; DeSantis, Ma, Goding, Newman, & Jemal, 2017; 
Dietze, Sistrunk, Miranda-Carboni, O'Regan, & Seewaldt, 2015). Furthermore, African 
American women under 40—who are younger than the recommended mammography screening 
age—not only have the highest incidence of breast cancer, but they also have the highest 
mortality rate of all racial groups (Anders, Johnson, Litton, Phillips, & Bleyer, 2009; Bleyer, 
O’Leary, & Ries, 2006). Finding ways to reduce these disparities is a pressing public health 
concern. 
Genetic testing for hereditary breast cancer mutations provides a unique pathway to 
prevention and treatment of breast cancer, especially among African American women (Force, 
2019). Hereditary breast cancer accounts for between 5 and 10 percent of all breast cancers 
(Force, 2019). However, African American women who meet the current hereditary breast 
cancer mutation counseling and testing profile utilize genetic counseling services at lower rates 
than their White women, making prediction of rates in this population difficult (Peterson et al., 
2020).  Researchers found that 20% of African American women with triple negative breast 
cancer had a BRCA1/2 mutation (Breast cancer 1 and Breast cancer 2 mutations) and that those 
diagnosed with triple-negative breast cancer at younger ages had an even higher percentage of 
BRCA1/2 mutations (Pal et al., 2015). Further, they found that 22 percent of the African 
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American women under the age of 35 had a BRCA1/2 mutation (Pal et al., 2015). Another 
retrospective cohort study with young women with early onset of breast cancer found that 
African American women had the highest prevalence of hereditary breast cancer mutations 
(18.2%) in their sample(Jones et al., 2019). The presence of hereditary breast cancer mutations in 
African American women is important because mutation carriers have an elevated risk of 
developing breast cancer from 40-80% over their lifetime, compared to the average lifetime risk 
of 12% (DeSantis et al., 2017; Kuchenbaecker et al., 2017; Petrucelli, Daly, & Feldman, 2010). 
Hereditary breast cancer mutation carriers are also typically diagnosed with breast cancer at early 
ages, and BRCA1 mutation carriers, specifically, are largely diagnosed with triple-negative breast 
cancer (Chen et al., 2018).  
Current recommendations for genetic counseling and testing for hereditary breast cancer 
mutations from the National Comprehensive Cancer Network (NCCN) states the necessity of 
either a family or personal cancer history suggestive of having a hereditary breast cancer 
mutation (Force, 2019; Institute, 2018 ). However, given recent study findings indicating that the 
current screening criteria are not capturing all women with hereditary breast cancer mutations, 
there has been a call for population-wide testing (PWT) for all women in the United States 
starting at age 30 (King, Levy-Lahad, & Lahad, 2014). This potential shift in screening 
recommendations would remove the need to rely on an individual’s knowledge of their family 
history and the need for physician recommendation for testing for hereditary breast cancer 
mutations (King et al., 2014). Lack of physician recommendation for screening has consistently 
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been cited as a major contributor to African American women’s lower rates of utilization of 
genetic testing for hereditary breast cancer mutations (Armstrong, Micco, Carney, Stopfer, & 
Putt, 2005; McCarthy et al., 2016; Peterson et al., 2020). Therefore, if implemented, the potential 
benefits of PWT need to be communicated to all women, but especially to younger African 
American women, given the breast cancer disparity that disproportionately impacts them. 
Existing research has focused on the perspectives and knowledge levels about hereditary 
breast cancer mutations of African American women (<40) with a family or personal history of 
breast cancer suggestive of a mutation (Adams, Christopher, Williams, & Sheppard, 2015; 
Hughes, Fasaye, Lasalle, & Finch, 2003; Hurtado-de-Mendoza, Jackson, Anderson, & Sheppard, 
2017; Kessler et al., 2005; Sheppard et al., 2014; Sheppard, Mays, Tercyak, & LaVeist, 2013). 
Lack of knowledge, high cost of testing, medical mistrust, limited access to healthcare, and lack 
of physician recommendation fuels their lower utilization of genetic counseling services (Adams 
et al., 2015; Hurtado-de-Mendoza et al., 2017; McCarthy et al., 2016; Sheppard et al., 2014; 
Sheppard et al., 2013; Thompson et al., 2012). However, not much research has focused on 
capturing the perspectives of hereditary breast cancer mutations of African American women 
without a family history suggestive of a hereditary breast cancer mutation(Adams et al., 2015),  
and only one study has captured their attitudes about PWT for hereditary breast cancer mutations 
(Rubinsak et al., 2019). Further, to date, no studies have focused on the perspectives of young 
women, particularly young African American women, about this potential shift towards PWT 
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despite their heightened risk for early onset of breast cancer and triple negative breast cancer 
compared to other racial groups.  
The millennial generation of African American women born between 1982 and 2004 
came of age during the technology revolution and, most recently, during the rise of direct-to- 
consumer genetic testing that can be used to provide answers about their ancestry and health 
without the need for a physician recommendation. Direct-to-consumer genetic testing services 
(DTC testing), such as Ancestry.com and 23andMe, are steadily increasing in popularity in the 
United States (Bowen & Khoury, 2018). To date, there have been a limited number of studies 
that provide insight into DTC testing uptake and the perspectives of racial minorities on DTC 
testing (Bloss et al., 2010; Carroll et al., 2019; Hensley Alford et al., 2011; Landry et al., 2017). 
These studies have found that African Americans use DTC testing at similar rates as their White 
counterparts and are more interested in using these services to learn about their ancestry than 
disease information (Carroll et al., 2019; Landry et al., 2017). However, none have focused 
specifically on young African American women’s perspectives of DTC testing services in 
relation to genetic counseling and testing for hereditary breast cancer mutations. There are 
distinct differences between DTC testing and population-wide testing in that DTC testing is 
largely handled by private companies whereas PWT would be implemented by the healthcare 
system.  Despite these differences, young African American women’s perspectives on an already 
widely available genetic counseling and testing service, such as DTC testing, could provide 
further insight into their perspectives about PWT in the future.  
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Understanding why people do or do not engage in health protective behaviors should be 
informed by appropriate theoretical frameworks. The Integrative Behavioral Model provides a 
robust framework to best understand young African American women’s perspectives of DTC 
testing, genetic counseling and testing for hereditary breast cancer mutations, and PWT in the 
future (Fishbein & Cappella, 2006). This theory posits that the most salient determinant for an 
individual to perform a health behavior is behavioral intention (Glanz, Rimer, & Viswanath, 
2015). Furthermore, it states that an individual’s intentions to perform a behavior are influenced 
by their perceived norms, attitudes, environmental constraints, knowledge, habits, perceived 
importance of the behavior, and their personal agency (Fishbein & Cappella, 2006; Glanz et al., 
2015). The purpose of this paper is to address this significant gap in the literature by using the 
Integrative Behavioral Model to examine the perspectives of African American women from the 
millennial generation (ages 18-30) towards PWT for hereditary breast cancer mutations who, if 
PWT was implemented, would be coming of age during this shift.  
Methods 
 
Focus groups were conducted as part of a larger sequential exploratory mixed methods 
study to inform the development of a survey on the same topic. To obtain a more representative 
sample to inform the development of the larger online survey, focus group participants included 
women who were university students and community-based residents not attending college. A 
multi-prong convenience sampling approach using flyers, social media, emails, and word of 
mouth was used to recruit focus group participants in the Greater Richmond Area, including at 
Virginia Commonwealth University and Virginia Union University. The recruitment messages 
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provided information about the opportunity to discuss African American young women’s 
perspectives of hereditary breast cancer mutations and their health communication preferences.  
Participant inclusion criteria included: a) women who self-identified as African American and/or 
Black; b) between the ages of 18 and 30; c) residence in the Greater Richmond area, and/or) 
enrolled in undergraduate or graduate studies at either Virginia Commonwealth University or 
Virginia Union University. We conducted seven focus groups (n=39). Four focus groups were 
conducted with community residents and three with students from Virginia Commonwealth 
University or Virginia Union University. This study was approved by the Institutional Review 
Board at Virginia Commonwealth University (HM200015881).    
Procedure 
Upon arrival to the focus group, participants were provided an information sheet which 
included the study purpose, voluntary nature of their participation, minimal risks associated with 
their participation, payment for participation, and encouraged participants to ask any questions. 
Focus groups were conducted by the first author. The first author, an African American female, 
who is currently a PhD candidate in Social and Behavioral Sciences, has extensive training and 
experience in conducting focus groups. Focus groups were conducted between July and October 
2019 and lasted approximately 30 to 45 minutes. The focus groups were hosted in the afternoons 
to best accommodate both students and community members’ schedules. Participants also 
completed a demographic survey after reading the study information sheet.  The demographic 
survey included questions about residency, age, racial and ethnic background, marital status, 
employment status, college enrollment status, and family history of breast cancer.  Both 
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community and student focus groups were held in private rooms at Virginia Commonwealth 
University and Virginia Union University. Participants received a $15 Target gift card upon 
completion of the focus group.  
Instrumentation  
Using semi-structured questions developed informed by the Integrative Behavioral 
Model, the focus group guide elicited participants’ knowledge of hereditary breast cancer 
mutations as well as their perspectives towards DTC testing, genetic counseling and testing for 
hereditary breast cancer mutations, and PWT in the future. The moderator guide began the group 
by reading a short introductory question: “Companies, such as 23andme and Ancestry.com, now 
offer genetic testing to the public for a small fee that provide information about the links between 
their genetic information and their health: What do you think of these services? Examples of 
questions included in this analysis are: What, if anything, have you heard about the hereditary 
breast cancer mutations? What do you think are the advantages of undergoing genetic 
counseling and testing for hereditary breast cancer mutations?  What do you think are the 
disadvantages of undergoing genetic counseling and testing for hereditary breast cancer 
mutations?  Participants were also asked about their perspectives and motivations about 
participating in any future potential shift towards PWT for hereditary breast cancer mutations 
including: What do you think about the potential shift towards PWT for hereditary breast cancer 
mutations? What would motivate you to participate in PWT for hereditary breast cancer 
mutations? What would deter you from participating in PWT for hereditary breast cancer 
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mutations? All focus groups were audio-recorded and transcribed verbatim by a professional 
transcription service, Rev.com.  
Data Analysis  
SPSS was used to analyze quantitative demographic data. Focus groups were analyzed by 
the first author (AH) and a graduate student, both of whom are trained in qualitative analysis. 
Coders conducted a thematic analysis of the data using MAXQDA software (Braun & Clarke, 
2006). The primary author created a preliminary codebook by reading and re-reading the 
transcripts to search for patterns in the data and subsequently created initial codes. These patterns 
and initial codes were organized around the focus group questions. After the creation of the 
preliminary codebook, both coders read and assigned codes to each transcript independently. 
Coders met weekly to refine existing codes, add any additional codes emerging from the data, 
finalize the codebook, and reach consensus on any coding discrepancies.  Overarching themes 
were created using the constant comparative method of grouping and ordering codes.  
Results 
The majority of the participants identified themselves as Black or African American 
(97.4%) with only one participant identifying as Black and Hispanic (2.5%), and the majority 
lived either in Richmond City (59%) or Henrico County (23%). Most participants were 
unmarried (94.9%), had full-time employment (76.9%), and were enrolled in college (64.0%). 
Most were either college freshmen (12.8%), juniors in college (10.3%), seniors in college 
(15.4%), or graduate students (17.9%). Lastly, there were slightly more participants without a 
family history of breast cancer (53.8%) than participants with a family history (46.2%). 
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Five overarching themes emerged from the focus group discussions: 1) perceived benefits 
and barriers to participating in direct to consumer testing (DTC testing); 2) limited knowledge 
about hereditary breast cancer mutations; 3) perceived advantages and disadvantages of testing 
for hereditary breast cancer mutations; 4) motivators and barriers to participating in PWT; and 5) 
concerns prior to rolling out PWT to the general public.  
Benefits and barriers to participating in direct to consumer testing. Participants 
expressed benefits including helping them to connect with family members and providing 
information about their health risks to participating in DTC testing services, such as 
Ancestry.com and 23andMe. Some participants described these services as a helpful resource to 
connect them with other family members. One participant commented: 
“I used Ancestry.com, and I really liked knowing some type of association of where my 
family history was. I did like being able to see what types of tribes were mixed in my 
blood, and mixed and mingled. It allowed me to connect with family members I had no 
idea existed.”  
 Other participants mentioned the utility of using these online testing services to provide 
them with information about their health and risk factors for disease. One participant stated:  
“I think in theory, that’s super helpful, and I have a history of breast cancer in my family, 
so for me it feels like if I’m genetically predisposed. Then I agree there are external 
factors that influence our health for sure, but to know that, oh, okay, there’s something in 
my body that leaves me more likely, than I feel like I would want to know.”  
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  Participants also expressed environmental constraints surrounding DTC testing. 
Participants expressed concerns about both the accuracy and confidentiality of their results. One 
participant commented: But personally I wouldn’t try it because ... I’m a really paranoid person. 
“So yeah, they say it goes... but do we really know? And could the results even be that 
accurate?” Another participant indicated that she had doubts about who would be reviewing the 
results: “So you and I feel like it’s not really guaranteed that there’s a specific doctor looking at 
those tests. Like you’re sending it to somebody on the internet.”  
Participants also highlighted concerns about the confidentiality of their genetic 
information if sent to a DTC testing company. One participant stated:  
“Yeah I’ve always heard about the 23andMe, the whole government thing. I guess 
they’re watching you, they’re keeping track of what you’re doing, putting you in the 
system. So I’ve always been kind on the fence about it, but being a biology major, I feel 
like it could be good.” 
Another participant connected her concerns about the confidentiality of her genetic information 
to how it could be used to negatively impact her in the future as Black person in America: “My 
thing like the way black people are being set up like, “Oh, we found your DNA at this scene.” 
I’m like, how? I wasn’t there.” 
Limited knowledge about hereditary breast cancer mutations. Many participants either 
had no knowledge or limited knowledge about hereditary breast cancer mutations. Some 
participants responded that they had not heard anything about the hereditary mutations including 
this participant: “I honestly have not heard anything about it.” Many participants highlighted 
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hearing about the hereditary nature of the mutations and having a partial understanding of the 
mutations. A participant commented:  
“I haven’t heard much of it, honestly. I just know that breast cancer can sometimes be 
hereditary in your family and some family members take precautions with their children 
at young ages to make sure that they don’t go through that.”  
Other women highlighted what they have learned from either their own or a friend’s family 
history of breast cancer. One woman stated:  
“Yeah, I don't really know what that means to be honest. I'm not even gonna lie. I've 
never heard of mutation, or I don't know what that is, but I've just heard my grandmother 
had breast cancer and so when I was like 17 or 18, we all go to the same doctor, me, my 
grandmother and my mom. So my doctor would always tell me ... She would always like, 
you know, when you get your Pap, she would check my breasts and tell me how to do it at 
home. But as far as the mutation, I don't really know.” 
Interestingly, despite having limited knowledge about the hereditary breast cancer mutations, a 
few participants referenced the heightened risk of breast cancer amongst African American 
women. A participant said:   
“Breast cancer doesn't run in my family, but I have friends whose moms have had it. So 
they get tested often. I've got people I know that it's literally been like "Grandma had it. 
So my aunt had it." And so I do know that black, well this might be incorrect, but black 
women can get some of the most aggressive forms of breast cancer.” 
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Perceived advantages and disadvantages of testing for hereditary breast cancer 
mutations. Many participants mentioned many advantages to testing for hereditary breast cancer 
mutations including early detection, being informed, and potential lifestyle changes. Participants 
consistently highlighted the importance of early detection of breast cancer as an advantage of 
genetic counseling and testing for hereditary breast cancer mutations. One participant 
commented:  
“But you go to the eye doctor and they ask you to do that extra test. That extra test can 
save you from glaucoma and stuff like that. So that extra test for breast cancer mutations, 
can help you for your future instead of later on down the road. You’re now sick and can’t 
really do anything.”  
In a similar vein, these participants also cited the importance of being informed about their risk 
for breast cancer in the future as an advantage of genetic counseling and testing for hereditary 
breast cancer mutations.  One participant commented:  
“I really think it’s just a matter of being better informed because, I mean science is 
advancing at a rate that’s out of this world these days. But I feel like there’s still a lot of 
things that go under the radar in terms of scans and all of those things that just go unseen 
and I think genetic testing would just give a leg up in terms of knowing a little bit more 
when it comes to things that may be going on that you can’t see.” 
Some also noted the importance of being informed about their hereditary breast cancer mutation 
status as it relates to their future childbearing decisions. One participant stated: “So with the 
breast cancer, not so much the partner part, but as far as okay, I know I carry this gene. So if I 
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have a child it may pass on to my child. Do I want to do that? It lets you have options at least 
upfront.”  
Participants also pointed to the lifestyle changes that could be made based upon their 
knowledge of the hereditary breast cancer mutation status. One participant commented: “Now I 
would want to make sure that I’m living a certain lifestyle in order to prevent certain things to 
enter into my body, or for our body to mutate in any other way. I feel like that kind of 
information would be important to me.” 
Participants cited multiple disadvantages to undergoing genetic counseling and testing for 
the hereditary breast cancer mutations.  Some women mentioned the fear that they have around 
getting testing for hereditary breast cancer mutations. One participant commented:   
“I feel like it could definitely scare somebody a lot. Yeah, we said it would be informative 
to let your kids know and stuff like that, but a lot of people could go about that as 
completely changing their lives, and just never fully living to the best of their ability 
because they’re like, Oh, what if I die because of breasts… You have that in the back of 
your head the whole time.” 
Others mentioned the potential impacts of finding out that they have a hereditary breast cancer 
mutation on their mental health. One participant stated: “It may make me live a healthier 
lifestyle. But I could totally see just slipping into depression about my fate and all of that. Yeah 
because I would worry all the time too.”  
Medical mistrust of genetic counseling and testing for hereditary breast cancer mutations 
were constraints for some participants. Some participants expressed mistrust of the accuracy of 
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the test results and concerns about the privacy of their genetic information. One participant 
stated: “What if they make a mistake? They were wrong or something. I’ve chopped off both my 
breasts. Can’t take that back. So it definitely would impact your life from now on.” Another 
participant mentioned being afraid that her genetic information would be used to create a “clone” 
in the future.  
Some participants wondered how they would be able to afford to get the testing and 
whether it would be included in their current insurance plans:  
“I feel like one, it just depends on how much they’re going to incorporate in people’s 
insurance plans. Are you going to have to come out of pocket? I’m just trying to do that 
cause, because at this point, I would like to but it’s like, I’m not really sure.”  
Motivators and barriers to participating in potential PWT. When asked about what 
would motivate them to participate in PWT, they identified multiple factors including, family 
history of breast cancer, healthcare quality, and being informed for themselves and their current 
and future family. Having a family history of breast cancer was a strong motivator to participate 
in PWT. One participant commented:  
“I would do it. My motivations are my health, and recognition of family history... and two 
people, it's not a lot of people, but it's more than enough people to feel like that they're 
not too many generations removed. So, if there is a genetic component to it, then I would 
want to know. I would be in the room shaking and probably, like, somebody hold my 
hand, but I think that would be enough motivation to get me to go.”  
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Belief that they would receive quality health care would also be a motivator for some 
participants. One participant said:  
“I think if I was to know that I would be treated like an individual because a lot of time 
they like to branch us all into one cure all for everyone, and that's not the case because 
everybody is different. So, as long as I know somebody is going to cater to my needs, not 
a group of people.” 
Having children was also identified as a motivating factor in their participation in PWT for 
hereditary breast cancer mutations. One participant said:  
“I'm just a wild card out here in these streets. I think I'd probably be more motivated if I 
had children, if I'm being honest. If I had a little girl or a little boy, but more specifically 
a little girl, who I was raising, and I wanted to protect them at all costs... I think that 
would probably be a huge motivation for me; and it's probably currently a huge 
motivation for a lot of women in taking care of themselves and getting checked out.”  
 Medical mistrust particularly related to health care quality, provider competence, 
accuracy of diagnosis, confidentiality, as well as appropriate usage of genetic information was 
mentioned by several participants as barriers to participating in population-wide testing. One 
participant stated: 
“I would just be more concerned kind of saying what you got to say is that the person 
who's doing it is skilled and educated enough to know what they're doing. Because if it is 
something so new, I'm sure people can be getting misdiagnosed all over the place.”  
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Another participant pointed to the importance of African American’s not being exploited during 
the roll out of PWT: “I'm all for it. If it doesn't disenfranchise us. I'm over that. I think everyone 
at this [point] is over that. So we can do it, but just don't take from us.”  
Affordability of the testing would be a major deterrent to their participation in PWT. One 
participant stated: “If it comes with a cost that we cannot afford, don't offer me that. That's like a 
spit in my face.” Similarly, insurance coverage in their decision and ability to participate in 
PWT: “If my insurance doesn't cover it and it's a lot of money, I probably wouldn't do it unless I 
absolutely needed to.” 
Concerns prior to rolling out PWT. Participants also highlighted concerns about the roll-
out of PWT to the general public that they believed should be considered. Many of the 
participants were concerned about potential access barriers including how inclusive and 
accessible the rollout would be to underrepresented ethnic and racial groups and socio-
economically disadvantaged groups. For instance, one participant stated:  
“I mean you already know so much going on right now with healthcare, and it seems like 
the more and more that things become available to everyone, specifically for African 
Americans. And I’m not saying by any means like we should be exclusive, but I just see 
an issue arising with it not being the same. What’s to say that if you say genetic 
counseling across every single state, Virginia is going to have the same set up as 
California? Are we going to have the same access to different resources?”   
Another participant pointed to the concern for access for individuals who are socio-economically 
disadvantaged: “When you think of doctor visits, you have to think about people who have access 
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to health care. So in my mind, I’m wondering if certain populations will get more help with this 
type of thing than others. Because they have more access to go to the doctor and talk to 
someone.”  
Some participants also pointed to the newness of genetic counseling and testing for 
hereditary breast cancer mutation and the need for additional research for them to be comfortable 
with participating. One participant commented:  
“Once again I don’t know why my brain is going this way, but I think about the HPV 
shots. When the first came out, my mom was like “You’re not getting that. It needs to be 
tested more, and this, this that and the other.” And I think it’s going to be the same way if 
that is brought up population-wide.”  
Along this vein, participants also spoke about the need to integrate PWT in both the medical 
field and society at large if it is to be successful. One participant stated: 
“I think you could probably be like integrated more into your pediatric care. Like how 
your physician tells you, “Oh, you got to take this for if you’re having sex or if you’re 
sexually active and all that. But no one ever touches the topic of breast cancer at all. It’s 
just never really talked about as you get older until, you reach a certain age, and it’s like. 
“Oh, I guess I should get a mammogram.” 
 Other participants highlighted the need for PWT to become more of a “mainstream thing” first, 
before it is likely to have any traction amongst young black women.   
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Discussion 
This current study examined the perspectives of young African American women (ages 
18-30) about genetic counseling and testing if there was to be a shift towards PWT in the United 
States.  Given existing breast cancer and genetic counseling and testing utilization disparities, it 
is imperative to understand the perspectives of millennial African American women about this 
potential shift in testing guidelines. This group has largely been absent from conversations 
around genetic counseling and testing for hereditary breast cancer mutations unless they were 
breast cancer survivors themselves (Jones et al., 2016).  The potential of PWT for genetic 
counseling and testing for hereditary breast cancer mutations for every woman regardless of 
family history, beginning at age 30, appears to be imminent (Buchanan et al., 2020; King et al., 
2014).  Therefore, the perspectives of African American women between the ages of 18 and 30 
who have not been affected by breast cancer provide key insights into potential knowledge gaps, 
attitudes, and environmental constraints that can be addressed in the development of future PWT 
interventions with this population.  
 This is the first known study to explore young African American women’s perceptions of 
seeking information about their health risks and ancestry through direct to consumer testing 
platforms such as, 23andMe and Ancestry.com. Participants in this study identified multiple 
benefits and barriers to utilizing existing DTC testing services. Similar to prior research findings, 
participants in this study also indicated that DTC testing services are useful to connect them with 
other family members and to learn about their health (Carroll et al., 2019; Landry et al., 2017). 
Consistent with prior research on African American women’s perspectives of traditional clinical 
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genetic testing, cost and medical mistrust were major environmental constraints to DTC testing 
(Sheppard et al., 2013). Participants also expressed concerns about accuracy and confidentiality 
of their test results from DTC testing companies.   
 Consistent with prior studies, participants had limited knowledge of hereditary breast 
cancer mutations (Adams et al., 2015; Sheppard et al., 2014). If PWT is made available, this 
finding highlights the need for greater education in this group about hereditary breast cancer 
mutations. Hurtado de Mendoza et al. (2017) found that knowledge is a key factor impacting 
genetic counseling and testing engagement amongst African American women at high risk for 
being a hereditary breast cancer mutation carrier (Hurtado-de-Mendoza et al., 2017). Therefore, 
education about hereditary breast cancer mutations will need to be a key component in health 
communication messaging and the design of future PWT interventions with this group.  
Participants had similar perceived advantages and disadvantages of current model of 
genetic counseling and testing for hereditary breast cancer mutations as African American 
women in prior studies (Adams et al., 2015; Sheppard et al., 2014; Sheppard et al., 2013).  
Benefits of testing, such as early detection, being informed about their carrier status, and 
potential lifestyle changes that they could make if they possess the gene, mirror those found in a 
previous study with African American women in Washington, D.C (Adams et al., 2015).  Similar 
to past studies (Adams et al., 2015; Sheppard et al., 2013; Sutton, He, et al., 2019), the 
participants in this current study also indicated that medical mistrust would be a major barrier to 
their participation in traditional genetic counseling and testing for hereditary breast cancer 
mutation.  These women expressed concerns not only about the accuracy of the test but also the 
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confidentiality of their test results. A recent study found that African American women had 
moderate levels of confidence in the Genetic Information Non-Discrimination Act (Sutton, 
Henderson, et al., 2019). However, the concerns surrounding data confidentiality expressed by 
participants may be related to a lack of knowledge of GINA and its protections amongst African 
American millennial women.  
When asked specifically about the potential shift towards population-wide availability of 
testing for hereditary breast cancer mutations, participants were concerned about possible 
disparities in screening practices amongst underrepresented racial and ethnic groups and socio-
economically disadvantaged groups that could occur if PWT becomes widely available.  They 
were hyper-aware of the potential widening of disparities that could occur due to existing 
inequities as it relates to differential medical screening practices and quality of care based on 
race and socio-economic status. Given the current shortage of genetic counselors, access to these 
services would be an important concern, especially in underserved communities (Bookman & 
News, 2016).  Similar to the disadvantages that participants highlighted in reference to the 
current model for genetic testing for hereditary breast cancer mutations, medical mistrust and 
affordability continue to be significant barriers to their participation in PWT for hereditary breast 
cancer mutations.   
Limitations and Future directions 
One limitation to the current study is that this was a convenience sample of primarily, 
college students at 31.6% of the community group were also college students. Therefore, the 
findings from this study may not represent the perspectives of non-college attending African 
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American women. This group may face additional barriers, including lack of access to a genetic 
counselor and competing priorities, that prevent them from participating in PWT.  Future 
research should examine the perspectives of low income African American millennial women to 
explore whether their perspectives of PWT may differ from the women in this study. Another 
limitation was that the young women’s intentions to participate in PWT was not directly assessed 
during the focus groups. However, factors that impact their willingness to participate according 
to the Integrative Behavioral Model were probed (i.e. motivators, barriers). Future research needs 
to examine the factors that influence young African American women’s intentions to participate 
in PWT in the future.  
Implications  
This study has implications for existing health care policies surrounding genetic 
counseling and testing for hereditary breast cancer mutations. Given the participants’ concerns 
about the cost of PWT, policies will be need to be created that make PWT accessible for all. The 
Affordable Care Act currently addresses the cost of genetic counseling and testing for women 
who are considered to be at high risk for being BRCA1/2 mutation carrier (Walcott & Dunn, 
2015). However, the cost of genetic counseling and testing for women who do not meet the 
screening guidelines for traditional genetic counseling and testing for BRCA1/2 is not covered 
(Walcott & Dunn, 2015).  Policymakers will need to extend this policy to cover all women in the 
U.S. if PWT is implemented in the future. The Affordable Care Act currently lacks the provision 
of coverage for risk-reducing interventions including, chemoprevention, frequent 
mammography, and preventive double mastectomy, that are the recommended next steps for 
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patients who find out that they carry a hereditary breast cancer mutation (Walcott & Dunn, 
2015). This is an important missing provision under the current guidelines, however if PWT is 
implemented in the United States, it will be critical that this provision is added and made 
available to all women but especially to young African American women who have concerns 
about the affordability of PWT in the future.  
This study also has implications for genetic counselors who will be a part of the PWT 
process. Given the high levels of medical mistrust expressed by women in this study, genetic 
counselors will need to have cultural competency training as well as learn strategies to build trust 
with members of this population. Prior implicit bias simulation research by Schaa et al. (2015) 
with genetic counselors indicated that most genetic counselors in their study had either a 
moderate or strong pro-White bias (Schaa, Roter, Biesecker, Cooper, & Erby, 2015). This pro-
White bias led to genetic counselors in the study not building rapport and being verbally 
dominant in conversations with simulated Black clients (Schaa et al., 2015). Addressing potential 
biases amongst genetic counselors will be particularly helpful in improving health 
communication and building trust with African American patients.  
Conclusion 
African American women continue to be disproportionately impacted by breast cancer 
and are more likely to succumb to the disease than any other racial group. Population-wide 
testing is a potential pathway to breast cancer prevention for young African American women in 
the United States. However, if long standing barriers facing the African American community, 
such as lack of knowledge about hereditary breast cancer mutations, cost, and medical mistrust 
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are not addressed, then the genetic counseling and testing utilization gap will only continue to 
widen.  Targeted health promotion programs will need to be implemented to increase knowledge 
of hereditary breast cancer mutations, the Genetic Information Non-Discrimination Act, and to 
help with visibility of PWT within this population. Policies will also need to be amended and 
created to provide insurance coverage for not only genetic counseling and testing but also any 
risk reducing interventions that are necessary for hereditary breast cancer mutation carriers. 
Furthermore, medical mistrust is a particularly important barrier that will need to be addressed 
by cultural competency trainings and the recruitment of African American students into the 
genetic counseling profession.  Lastly, issues of access will also need to be addressed to 
determine how such a service could be economically and geographically accessible for all.   
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Predictors of young African American women’s intentions to participate in potential population-
wide testing for hereditary breast cancer mutations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
Abstract:  
Young African American women (<40 years) are twice as likely to die from breast cancer than 
White women. Preventive efforts, including population-wide testing for hereditary breast cancer 
mutations for all women in the United States beginning at age 30, are being considered as 
potential pathways to breast cancer prevention for all women.  This paper examines factors that 
influence intentions to participate in potential population-wide testing in a sample of 170 African 
American women. Participants in this study were between the ages of 18 and 30 and did not have 
a known hereditary breast cancer mutation. Simple and multiple regression models assessed the 
relationship between factors and participants’ intentions to participate in population-wide testing.  
Participants had moderate knowledge levels of hereditary breast cancer mutations and moderate 
to high levels of medical mistrust.  Simple regressions indicated that subjective norms (B = .460, 
p = .000) and motivators to participate in direct to consumer testing (B = .217, p = .004) were 
positively associated with intentions to participate in potential population-wide testing.  
Subjective norms (B = .449, p = .000) and motivators to participate in direct to consumer testing 
(B = .204, p =.009) remained significant after accounting for sociodemographic variables. 
Findings suggest that family-based and social network interventions as well as public health 
campaigns that target social networks would be particularly well-suited for this population. 
Furthermore, it will be important to better understand the linkages between young African 
American women’s current participation in direct to consumer testing and their intentions to 
participate in population-wide testing.  
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Introduction  
African American women are most likely to die from breast cancer at every age when 
compared to White women (DeSantis et al., 2019; Society, 2020). Breast cancer amongst young 
women is rare. However, young African American, who are younger than the recommended 
mammography screening age (< 40 years), are twice as likely to die from breast cancer, have the 
highest incidence of breast cancer of all racial groups, and the highest rates of an aggressive form 
of breast cancer, triple negative breast cancer (Anders, Johnson, Litton, Phillips, & Bleyer, 2009; 
Bleyer, O’Leary, & Ries, 2006; DeSantis et al., 2019; Dietze, Sistrunk, Miranda-Carboni, 
O'Regan, & Seewaldt, 2015). Triple negative breast cancer lacks proper treatment and is 
associated with the presence of a hereditary breast cancer mutation. Studies with young African 
American women with breast cancer have consistently indicated that they have a high prevalence 
of hereditary breast cancer mutations (Jones et al., 2019; Pal et al., 2015). African American 
women who meet current screening recommendations for hereditary breast cancer mutations 
utilize genetic counseling and testing services at lower rates than White women (Armstrong, 
Micco, Carney, Stopfer, & Putt, 2005; McCarthy et al., 2016). Recently, there has been a 
growing interest in expanding hereditary breast cancer mutation screening to all women 
beginning at age 30 in the United States to promote breast cancer prevention (King, Levy-Lahad, 
& Lahad, 2014);  however, if implemented it is imperative to ensure that such screening does not 
widen existing breast cancer disparities impacting young African American women.  
Hereditary breast cancer mutations account for approximately 5 to 10 percent of all breast 
cancers (Force, 2019). The average lifetime risk of breast cancer amongst women is 12%; 
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however, hereditary breast cancer mutation carriers have an increased lifetime risk of breast 
cancer of between 40 and 80 percent (Kuchenbaecker et al., 2017; Petrucelli, Daly, & Feldman, 
2010). Similar to the experiences of African American women with breast cancer, hereditary 
breast cancer mutation carriers are typically diagnosed at younger ages and with triple negative 
breast cancer (Chen et al., 2018). Hereditary breast cancer mutation carriers have preventative 
options available to them including, more frequent mammography screening, chemoprevention, 
and mastectomy to reduce their risk of developing breast cancer (Force, 2019). However, given 
their lower rates of testing, African American women, who meet the current screening 
guidelines, have largely not been able to reap the preventive benefits of genetic counseling and 
testing for hereditary breast cancer mutations.  
More recently, there has been an increasing call for population-wide testing (PWT) 
largely prompted by recent studies indicating that up to 50 percent of hereditary breast cancer 
mutation carriers are missed with current screening criteria (King et al., 2014; Manchanda, 
Loggenberg, et al., 2015). Current screening guidelines from the National Cancer 
Comprehensive Network (NCCN) requires a personal or family history suggestive of a 
hereditary breast cancer mutation to be eligible for genetic counseling and testing (Force, 2019; 
Institute, 2018 ). However, PWT would eliminate this current model that hinges on physicians as 
gatekeepers to genetic counseling and testing for the mutations (King et al., 2014). Prior studies 
have indicated that PWT is cost-effective given the decreasing prices of genetic testing and that 
there is high interest amongst women in in this potential initiative (Manchanda & Gaba, 2018; 
Manchanda, Legood, et al., 2015; Rubinsak et al., 2019). If PWT were to be implemented, this 
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potential shift could be transformative for breast cancer prevention among African American 
women given that formative data has consistently linked the lower utilization of genetic 
counseling and testing for hereditary breast cancer mutations by African American women, who 
meet current NCCN testing guidelines, to the lack of physician referral for genetic counseling 
and testing (McCarthy et al., 2016). Other commonly cited barriers to their participation in 
genetic counseling and testing are lack of knowledge about hereditary breast cancer mutations, 
cost, medical mistrust, and concerns about their families’ negative perceptions towards 
participation in genetic counseling and testing  (Adams, Christopher, Williams, & Sheppard, 
2015; Hurtado-de-Mendoza, Jackson, Anderson, & Sheppard, 2017; Sheppard et al., 2014; 
Sheppard, Mays, Tercyak, & LaVeist, 2013). Prior to rolling out PWT, it will be important to 
preemptively understand and address any barriers that young African American women may 
experience to participating in PWT.  
There is a lack of research focusing on the perspectives of young African American 
women, who do not have a family history suggestive of a hereditary breast cancer mutation, 
towards genetic counseling and testing for hereditary breast cancer mutations. Currently, only 
one study includes African American women’s perspectives towards and acceptability of PWT; 
however, the mean age of participants in this study was 37.7 (Rubinsak et al., 2019). Moreover, 
there have not been any studies that focus on the factors that influence young African American 
women’s intentions to participate in PWT if it becomes available in the future. Young African 
American women between the ages of 18 and 30 are unique in that they have come of age during 
the rise of direct to consumer testing (DTC) services, such as Ancestry.com and 23andMe, which 
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are already widely available genetic testing services that provides information about health 
without the need for a physician recommendation. Studies indicate that African Americans 
utilize DTC testing at similar rates as Whites, however none have explored whether young 
African American women’s intentions to participate in PWT for hereditary breast cancer 
mutations are influenced by their perspectives toward DTC testing (Carroll et al., 2019; Landry 
et al., 2017).  Understanding the potential factors that influence young African American 
women’s intentions to participate in PWT will provide insight into behavioral interventions and 
public health campaigns for this group.  
The Integrative Behavioral Model provides a comprehensive framework to understand 
the factors that influence young African American women’s intentions to participate in PWT for 
hereditary breast cancer mutations. This theory indicates that the most important determinant for 
a person’s intentions to perform a health behavior is behavioral intention (Fishbein & Cappella, 
2006).  Furthermore, it states that an individual’s intentions to perform a behavior are influenced 
by their perceived norms, environmental constraints, knowledge, habits, attitudes, and their 
personal agency (Fishbein & Cappella, 2006).  This current paper aims to examine the factors 
that influence young African American women’s (ages 18-30) intentions to participate in PWT 
in the future. The main hypotheses for this study are:  
Hypothesis 1:  Participants will have low levels of knowledge about hereditary breast cancer 
mutations and low levels of medical mistrust. 
Hypothesis 2: There will be a positive relationship between participants’ attitudes towards direct 
to consumer testing and intentions to participate in PWT.    
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Hypothesis 3: There will be a positive relationship between participants’ subjective norms and 
intentions to participate in PWT. 
Hypothesis 4:  There will be a negative relationship between participants’ individual medical 
mistrust and intentions to participate in PWT.  
Hypothesis 5:  There will be a negative relationship between participants’ group-based medical 
mistrust and intentions to participate in PWT.  
Hypothesis 6:  There will be a positive relationship between participants’ perspectives towards 
hereditary breast cancer mutations and intentions to participate in PWT.  
Hypothesis 7:  There will be a positive relationship between their perceived risk of hereditary 
breast cancer mutations and intentions to participate in PWT. 
Hypothesis 8: There will be a negative relationship between participants’ perceived severity of 
breast cancer and intentions to participate in potential population-wide testing.  
 
Methods  
Survey Development  
An online survey was administered to assess the factors that influence young African 
American women’s intention to participate in PWT as a part of a larger sequential exploratory 
mixed methods study.  This survey was developed based upon the results of seven focus groups 
with young African American women (n=39) in a southern urban city that focused on 
perspectives of hereditary breast cancer mutations and motivators and barriers to participating  in 
PWT. Knowing that most participants may not know about PWT for hereditary breast cancer 
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mutations, high level definitions of commonly used terms such as DTC testing, genetic 
counseling, genetic testing, and PWT were included throughout the survey. An expert panel 
consisting of four academic scholars each with experience in survey development, hereditary 
breast cancer mutations, and breast cancer reviewed the survey developed by the first author.  In 
an effort to increase survey validity, the first author conducted two rounds of cognitive 
interviews using the verbal probing method to test and obtain feedback from members of the 
target population (Peterson, Peterson, & Powell, 2017). All discrepancies in the survey were 
resolved by two coders at the end of the second round of cognitive interviews.  
Sample and setting  
Surveys were distributed and administered in July 2020 by the online survey company, 
Qualtrics, to individuals in their existing online panels. Qualtrics randomly selected potential 
survey participants based on the demographic information in the profiles of users that were most 
likely to qualify for participation. Potential participants were sent an invitation to participate via 
email that informed them of the survey, survey length, incentives for participation, and the 
survey hyperlink. Potential participants who did not meet the established eligibility criteria were 
excluded from participation. Participant inclusion criteria included women who: 1) self-
identified as African American or Black, 2) were between the ages of 18 and 30, and 3) did not 
have a known hereditary breast cancer mutation in their family.  A power analysis was conducted 
using G*Power to determine the sample size in which the analysis would have a small effect 
(Cohen’s h=05). The power analysis indicated a sample of 160 would be sufficient. Quota 
sampling was used to stratify participants by age to ensure an equal number in each of the age 
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ranges, 18 to 24 and 25 to 30 (Brown, 2016; Feild, Pruchno, Bewley, Lemay, & Levinsky, 2006). 
Survey respondents were required to answer all questions to avoid skipped or missed survey 
responses. Participants were provided with various incentives for participation in the study that 
were provided by Qualtrics. Due to the exempt nature of this study, all participants were 
provided with an information sheet prior to the survey that outlined the purpose of the study, 
voluntary nature of participation, and minimal risks associated with participation in the study. 
This study was approved by the Institutional Review Board at Virginia Commonwealth 
University (HM200015881).  
Measures  
Predictors  
Breast Cancer Genetics Knowledge was assessed using a 11-item scale that measures 
knowledge about hereditary breast cancer mutations of women at risk for hereditary breast 
cancers (Erblich et al., 2005). All the items in the scale require true or false responses. This scale 
assessed the cancer risk associated with being a hereditary breast cancer mutation carrier, the 
prevalence of hereditary genes, familial patterns of hereditary breast cancer mutation inheritance, 
and various risk management options available to hereditary breast cancer mutation carriers. An 
overall score was created by summing the correct responses to the items. Higher scores indicated 
greater hereditary breast cancer mutations knowledge (scores range 0 to 11). 
Group-Based Medical Mistrust was assessed using a 12 item, 5-point Likert scale, that 
asks the respondent to think about the relationship between individuals of their race and the 
medical system (Cronbach’s alpha = .741) (Thompson, Valdimarsdottir, Winkel, Jandorf, & 
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Redd, 2004). It contains items, such as “Doctors have the best interests of people of my 
racial/ethnic group in mind” and “People of my racial/ethnic group cannot trust doctors and 
health care workers.” Responses range from strongly disagree to strongly agree. An overall score 
was created by summing item responses together with higher values indicating greater group-
based medical mistrust (range 0-60).  
Individual medical mistrust was assessed using a 7-item  yes or no response scale that 
examined participants’ experiences with discrimination in the healthcare field (Bird & Bogart, 
2001 ). The main question of this scale asks, “When getting health care, have you ever had the 
following things happen to you because of your race or ethnicity?” Respondents are then asked 
to respond yes or no to statements such as, “Been treated with less courtesy than other people” 
and “Received poorer service than others.” An overall score was created by summing item 
responses together with higher values indicating greater individual medical mistrust (scores 
range from 0 to 7) (Cronbach’s alpha = .818). 
 Perceived Risk of Carrying a BRCA1/2 Mutation was assessed by adapting a previously 
used Likert item, “How likely do you think it is that you carry a BRCA1/2 mutation (Sussner, 
Jandorf, Thompson, & Valdimarsdottir, 2013)?”  In this current study, the item asked, “How 
likely do you think it is that you carry a hereditary breast cancer mutation?” This was adapted in 
order to account for other hereditary breast cancer mutations that are not necessarily BRCA1/2 
mutations.  The possible responses to this Likert scale item ranged from not at all likely, 
somewhat likely, likely, very likely, and extremely likely. 
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Perceived Severity was assessed using a three item 5-point Likert scale that measures 
women’s perceived severity of carrying a gene mutation. It contains the following three items: 
1). “If I found out I carried a gene mutation, it would greatly disrupt my life,” 2) “Finding out I 
carried a gene mutation would be very difficult for me,” and 3) If I found out I carried a gene 
mutation, I would worry much more about developing breast cancer (Wang, Gonzalez, Janz, 
Milliron, & Merajver, 2007).”  The responses to these items range from strongly disagree to 
strongly agree (Cronbach’s alpha = .787).  An overall score was created by summing item 
responses with higher scores indicating greater perceived severity (scores range from 0 to 15).  
 Attitudes towards hereditary breast cancer mutations were assessed using a 13-item, 5-
point Likert scale that measures women’s perceived advantages and disadvantages to undergoing 
genetic counseling and testing for hereditary breast cancer mutations (Cronbach alpha=.662) 
(Thompson et al., 2002).  It contains items such as “Testing is not worthwhile because it could 
yield inconclusive results about whether I carry the gene for breast cancer” and “If I were found 
to carry the gene for breast cancer, I would worry about passing the gene to my children.” The 
possible item responses ranged from strongly disagree to strongly agree. An overall score was 
created by summing the correct responses together. Higher scores indicate greater perceived 
advantages of hereditary breast cancer mutations (scores range from 0 to 65). 
Subjective Norms were assessed by adapting a 5 item, 5-point Likert scale that asks 
women to consider what close relatives and friends would think of them undergoing genetic 
counseling and testing for BRCA 1/2. Example items include, “My parents would approve of me 
getting genetic testing and counseling for BRCA 1/2” and “My friends would approve of me 
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getting genetic testing and counseling for BRCA 1/2. Possible item responses range from strongly 
disagree to strongly agree (Cronbach’s alpha = .864). In this current study, scale items were 
reframed to focus on whether their friends, family, spouse, or other family member would 
approve of them getting genetic testing and counseling through PWT. An overall score was 
created by summing the items together. Higher scores indicate more positive subjective norms 
(scores range from 0 to 25).  
Attitudes towards Direct to Consumer Genetic Testing were assessed using two scales to 
understand respondents’ perspectives towards direct to consumer genetic testing 
(Mavroidopoulou, Xera, & Mollaki, 2015). The first 7-item, 5-point Likert scale explored 
respondents’ motivations to participate in DTC testing (scores range from 0 to 35) (Cronbach’s 
alpha = .829). An overall score was created by summing all the response items together. Higher 
scores indicated greater agreement with the potential reasons to participate in DTC testing. The 
second 4-item scale explored respondents’ reasons for not wanting to participate in direct to 
consumer genetic testing (scores range from 0 to 20) (Cronbach’s alpha = .612). An overall score 
was created by summing all of the response items. Higher scores indicated greater agreement 
with the potential reasons not to participate in DTC testing. Responses for both direct to 
consumer participation scales range from strongly disagree to strongly agree.  
Demographic Characteristics.  
 
The survey collected respondents’ age, race, income, level of education, family history of 
breast cancer, marital status, health insurance status, employment status, and whether they had a 
regular physician. For the analysis, family history of breast cancer was dummy coded as yes/no. 
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Education level was categorized into three levels: 1) less than or equal to high school, 2) any 
college to a Bachelor’s degree, and the referent category 3) graduate degree. Marital status was 
categorized into four levels: 1) married, 2) living together, 3) divorced, and the referent category 
4) never married.   
Outcome 
Intentions for potential population-wide testing for BRCA 1/2 scale was assessed by 
adapting an item that has been validated by a prior study on intentions that asks “At the present 
time, which of the following statements describes you best?” The possible responses to this 
Likert scale item are: definitely will have genetic testing, probably will have genetic testing, 
considering genetic testing, and not considering/thought about genetic testing (Lerman et al., 
1999). This item was adapted to ask, “Now try to imagine you are offered genetic testing and 
counseling for breast cancer susceptibility through a population-wide testing initiative at some 
point in the future, would you choose to have the test?” The possible responses to this Likert 
item are: no definitely not, no probably not, unsure, yes probably, and yes definitely.    
 
Statistical Methods   
Descriptive statistics were run to describe the variables of interest in this study. Total 
mean scores and standard deviations were computed for each of the continuous predictor 
variables. The dependent variable, intention, was assessed for normality. Unadjusted simple 
regressions were conducted to assess the relationship between each of the predictor variables (i.e. 
group-based medical mistrust, individual medical mistrust, perceived risk, perceived severity, 
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attitudes towards hereditary breast cancer mutations, subjective norms, and attitudes towards 
direct to consumer testing) and intentions to participate in population-wide testing. All 
assumptions were assessed and met for each of the unadjusted analyses. Variables were selected 
for separate adjusted multiple regression analyses based upon their significance in the initial 
unadjusted analyses. Each adjusted analysis accounted for potentially confounding variables, 
including family history, marital status, and level of education based upon findings from the 
initial focus groups. Multicollinearity was assessed for each of the adjusted analyses by 
conducting bivariate correlations. All analyses were conducted using SPSS 25.0.  
Results  
Among the individuals recruited for participation in the survey by Qualtrics, 391 
individuals opened the survey link and were presented the IRB approved information sheet. Of 
the 391 individuals who opened the link, 113 were ineligible to participate based upon the 
study’s inclusion criteria and an additional nine participants were over-sampled. Another 99 
failed to complete the survey. A total of 170 African American women between the ages of 18 
and 30 are included in the study sample. 
 Most participants attended some college (62.3%), were employed either full-time or part-
time (60.6%), never married (61.8%) and had an income less than $40,000 (55.3%). Further, 
most of the women in the study had a regular physician (65.3%), health insurance (68.2%), and 
did not have a family history of breast cancer (81.2%). The scores on the knowledge of 
hereditary breast cancer mutations scale ranged from 2 to 10 with a mean score of 6.1 (standard 
deviation = 1.53). The individual medical mistrust scale total range of scores were from 0 to 7 
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with a mean score of 6.6 (standard deviation = 2.33). The group medical mistrust scale total 
range of scores were from 12 to 58 with a mean score of 35.9 (standard deviation = 6.51) (Table 
1). 
 Table 1: Frequencies of Demographic Variables and Predictor Scale means 
 
Variables  N (%) Mean (SD)  
Demographic Variables   
Age  23.7 (4.00) 
                        18-24 years  85 (50%)  
                        25-30 years 85 (50%)  
Marital Status      
                        
                         Married  
 
20 (11.8%)  
                         Never married                               105 (61.8%)  
 
                         Living together  
 
 28 (16.5%)  
                         Divorced  17 (10.0%  
Education level     
                          Less than or equal to high school  64 (37.6%)  
                          Any College to a Bachelor’s Degree  92 (54.1%)  
                          Graduate Degree   14 (8.2%)  
Insurance Status    
                     
                          Yes  116 (68.2%)  
                          No 54 (31.7%)  
Income    
                          Less than $20,000  53 (31.2%)  
   
                          $20,000 -$39,999 
 
41 (24.1%)  
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                          $40,000-$59,999 
 
38 (22.4%)  
                          $60,000- $79,999   13 (7.6%)  
                          $80,000-$99,999   10 (5.9%)  
                          $100,000- $119,999     7 (4.1%)  
                          At least $120,000     8 (4.7%)  
Employment Status     
                         Full time   69 (40.6%)  
                         Part-time  34 (20.0%)  
                         Unemployed   24 (14.1%)  
                         Retired  4 (2.4%)  
                         Unable to work  6 (3.5%)  
                         Homemaker  11 (6.5%)  
                         Student    22 (12.9%)  
Family History of Breast Cancer    
                         Yes  32 (18.8%)  
                         No 138 (81.2%)  
Regular Physician    
                        Yes  111 (65.3%)  
                        No 59 (34.7%)  
Predictor Variables    
                       Attitudes towards BRCA1/2   42.0 (6.7) 
                       Subjective Norms   16.3 (4.4) 
                       Individual Medical Mistrust   6.6 (2.3) 
                       Group-based Medical Mistrust   35.9 (6.5) 
                       Perceived Severity       9.7 (2.9) 
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                       Perceived Risk      2.1 (1.9) 
                       DTC Motivations   24.9 (5.7) 
                       DTC barriers   11.5 (3.1) 
 
The dependent variable, intention, was not normally distributed as indicated by the 
Shapiro-Wilks test with a p-value of .000.  The majority of the responses to the intention to 
participate in PWT was “Unsure” (n = 75). There were not any statistically significant 
relationships between intention to participate in PWT and the simple regression models with 
group medical mistrust (B = -.075, 95% CI : [-.037, .012], p=.332), individual medical mistrust 
(B = .140, 95% CI: [-.005, .132], p = .070), reasons to not participate in direct to consumer 
testing scale (B = -.060,  95% CI: [-.073, .031], p=.436), perceived risk for hereditary breast 
cancer mutations (B =.066, 95% CI: [-.076, .194], p = .391), perceived severity (B = .124, 95% 
CI: [-.010,.101],p =.106), or attitudes towards hereditary breast cancer mutations (B = .070, 95% 
CI: [-.014, .038],p = .362) (Table 2). Subjective norms were positively associated with intentions 
to participate in PWT for hereditary breast cancer mutations (B =.460, 95% CI: [.077, .142], p < 
.000). Subjective norms accounted for 20.7% of the variation in respondents’ intentions to 
participate in PWT (F (1,168) = 44.99, p = .000). The relationship between subjective norms and 
intentions to participate in PWT remained statistically significant in the multiple regression 
model that accounted for family history of breast cancer, marital status, and level of education (B 
= .449, 95% CI: [.074, .141], p = .000).  The overall adjusted model remained significant (F, (7, 
162) = 6.60, p < .000). Motivations to participate in direct to consumer testing was also 
positively associated with intentions to participate in PWT for hereditary breast cancer mutations 
 
 
 
 
 
 
 
 
74 
in the simple linear regression (B = .217, 95% CI: [.013, .067], p = .004).  Motivations to 
participate in direct to consumer testing accounted for 4.2% of the variation of respondents’ 
intentions to participate in PWT (F (1,168) = 8.32, p = .004).  Despite the overall model not 
remaining significant (F (7,162) = 1.71, p = .110), the relationship between motivations to 
participate in direct to consumer and intentions to participate in PWT also remained statistically 
significant in the multiple regression model that accounted for family history of breast cancer, 
marital status, and level of education (B = .204, 95% CI: [.010, .066], p =.009).   
 
 
Table 2: Simple Linear Regressions with each of the Predictor Variables and Intentions for 
potential population-wide testing 
 
Dependent Variable 
Intention to participate in population-wide testing  
Predictor Variables Unstandardized beta  Standardized beta (p-value) 95% CI  Adjusted R
2  
Attitudes towards BRCA   .012       .070 (p = .362)  (-.014, .038) -.001 
Group-based medical mistrust                - .012           -.075 (p = .332) (-.037,.012)  .000 
Individual medical mistrust   .063             .140 (p = .070)  (-.005, .132) .014  
DTC Motivations   .040             .217 (p = .004) *   (.013, .067) .042 
DTC Barriers              -  .021          - .060 (p = .436) (-.073, .031)        -.002 
Perceived Risk   .059             .066 (p = .391) (-.076, .194) -.002  
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Perceived Severity .046             .124 (p = .106)            (-.010, .101) .010 
Subjective Norms   .110             .460 (p = .000) *                (.077, .142)  .460 
*p < .05 
 
Table 3: Multiple Regression models adjusting for marital status, level of education, and family 
history of breast cancer 
 
Model 1  
 
Beta  
 
95% CI  
 
P-
value 
Model 2  Beta   95% CI   P-value   
Constant   .923 (.178, 1.667) .015 Constant        1.68 (.789, 2.569) .000 
Subjectiv
e Norms    
 .449* (.074,.141) .000* DTC 
Motivation
s 
.204*    (.010, .066) .009*  
Marital 
Status  
   Marital 
status     
Married    .063 (-.267,.680) .390 Married   .102    (-.185, .848) .207  
Living 
together  
     
     .003 
   
 
(-.394, .409) 
 
.970 Living Together  .027 (-.361, .516) .728 
Divorced  
 
    -.002  
   
 
(-.506,.490) 
 
.975 Divorced  -.031 (-.654, .439) .698 
Never 
Married a 
 
 
 
 
 
 
Never 
Married a     
Educatio
n Status   
   Education 
Status     
Less than 
or equal 
to HS  
 
.143 
 
(-.261, .882) 
 
.285 
Less than 
or equal to 
HS 
.139 (-.325, .927) .344 
Any 
College 
to a 
Bachelor’
s  
 
 
.145 
 
 
 
 
(-.246,.857) 
 
 
.275 
Any 
College to 
a 
Bachelor’s 
.173 (-.238, .969) .233 
Graduate 
degree a 
 
 
 
 
 
 
Graduate 
degreea     
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Family 
history of 
breast 
cancer  
 
 
.044 
 
 
 
 
(-.254, .493) 
 
 
.528 
Family 
history of 
breast 
cancer  
.065 (-.238, .969) .396 
*p<.05 
 aReferent Group (coded 0) 
Discussion 
 This is the first known study aiming to understand the factors that influence young 
African American women’s (ages 18-30) intentions to participate in population-wide testing for 
hereditary breast cancer mutations. Preemptively understanding the factors that influence young 
African American women’s intentions to participate in PWT for hereditary breast cancer 
mutations is imperative given the existing breast cancer and genetic counseling and testing 
utilization disparities that exist in this population. Recent studies provide strong support for PWT 
to become a reality in the future (Manchanda & Gaba, 2018; Manchanda, Legood, et al., 2015; 
Rubinsak et al., 2019) citing cost-effectiveness, benefits for breast cancer prevention, and 
acceptability of this initiative. This study assessed African American women’s current 
knowledge of hereditary breast cancer mutations and their levels of medical mistrust. It also 
examined potential factors, such as attitudes and environment constraints, that could be 
associated with intentions to participate in PWT for hereditary breast cancer mutations if, and 
when, offered in the future.  
 Study participants indicated a moderate level of knowledge about hereditary breast 
cancer. The moderate knowledge of hereditary breast cancer mutations finding is particularly 
important given that knowledge has been found to be a significant predictor of genetic 
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counseling and testing uptake for hereditary breast cancer mutations amongst African American 
women (Hurtado-de-Mendoza et al., 2017). These findings are similar to a prior study with 
African American breast cancer survivors at risk for carrying a hereditary breast cancer mutation 
that have found that younger age was a significant predictor of having a higher knowledge of 
hereditary breast cancer mutations (Hurtado-de-Mendoza et al., 2017). Moderate knowledge 
levels amongst younger African American women could potentially be due to recent mainstream 
conversations about hereditary breast cancer mutations in the media (Leach, 2019). Discussions 
about hereditary breast cancer mutations have been included in popular television shows 
targeting young adults. In 2018, a popular show on ABC Freeform channel that targets young 
adults, The Bold Type, presented a storyline of a young 26-year-old woman getting tested and 
finding out that she had a hereditary breast cancer mutation and how being a mutation carrier 
impacted every aspect of her life throughout the season (Leach, 2019). Therefore, younger 
African American women may have been exposed to more information about hereditary breast 
cancer than older African American women who participated in past studies.  
 Subjective norms were positively associated with young African American women’s 
intentions to participate in any future PWT. Our findings differ from a prior study exploring 
factors that impact young African American breast cancer survivors’ with a slightly larger age 
range (ages 20-45) that found their uptake of genetic counseling and testing was not influenced 
by subjective norms (Jones et al., 2016). Differences between this current study may be due to 
the fact that participants in the prior study were diagnosed between the ages of 20-45 but 
participated in this study years later.  Findings from this current study are consistent with studies 
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that have focused on the introduction of new preventive health behaviors to young adult women, 
such as HPV vaccination. Previous studies have consistently indicated that subjective norms are 
positive predictors of young adult women’s intentions to get an HPV vaccination (Allen et al., 
2009; Gerend & Shepherd, 2012). Study findings suggest that, if PWT is implemented, family-
based and social network behavioral interventions will likely need to be conducted prioritizing 
young African American women as well as members of their social network. Family members 
can serve both as deterrents and motivators to African American women’s participation  in 
genetic counseling and testing for hereditary breast cancer mutations (Sheppard et al., 2014); 
therefore, social network intervention strategies are well-suited for this population given the 
potential diverse opinions of family members. Similarly, public health campaigns targeting 
young African American women will also need to reference social networks given the influence 
of families and friends. Lastly, though not examined in this study, it may also be important for 
future research to examine who exactly counts as social network members especially given the 
pervasiveness of social media engagement and social media influencer culture including the 
phenomenon of Facebook and Twitter friends and followers. 
 This is the first study to examine the relationship between young African American 
women’s motivations to participate in DTC testing and intentions to participate in PWT for 
hereditary breast cancer mutations. Our findings suggest that young African American women 
may be more open to direct to consumer testing and may in turn influence their perspectives 
towards PWT. This could potentially be attributed to the rise of marketing of direct to consumer 
testing to consumers that began with Myriad Genetics in 2006 (Matloff & Caplan, 2008). Direct 
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to consumer testing marketing has become increasingly popular with companies such as, 
23andMe and Ancestry.com, that advertise their services on all platforms (Estrada, 2017). Direct 
to consumer testing companies have not always effectively targeted African Americans in 
advertisements. Ancestry.com recently had to pull a controversial tv commercial, entitled 
“Inseparable”, after being accused of romanticizing the rape of an enslaved African American 
woman by her White slave owner (Kearns, 2019). Despite this missed opportunity to target 
African Americans, studies have consistently indicated that African Americans utilize DTC 
testing at similar to rates as Whites (Carroll et al., 2019; Landry et al., 2017). Future research 
should explore the linkages between young African American women’s intentions to participate 
in PWT and their current participation in already widely available genetic testing services 
offered through direct to consumer testing.  
Medical mistrust is a known predictor of African American breast cancer survivors’ 
participation in genetic counseling and testing for hereditary breast cancer mutations (Sheppard 
et al., 2014; Sheppard et al., 2013; Sutton et al., 2019). Consistent with prior studies, young 
African American women in this study had moderate to high levels of medical mistrust. 
However, despite having moderate to high levels of medical mistrust, neither individual or 
group-based medical mistrust were associated with young African American women’s intentions 
to participate in PWT. This finding suggests that while participants may distrust the medical 
field, distrust may not negatively influence their health behaviors in the same ways as it has 
traditionally among older African American breast cancer survivors. Future research should 
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examine the impact of medical mistrust on young African American women’s intentions to 
participate in PWT and subsequent uptake of PWT. 
Other factors that have been typically found to be associated with intentions and uptake 
of genetic counseling and testing for hereditary breast cancer mutations in prior studies with 
breast cancer survivors both young and old were not significant in this current study (Jones, 
McCarthy, Kim, & Armstrong, 2017; Kessler et al., 2005; Wang et al., 2007). Different from 
prior studies with African American women at-high risk for hereditary breast cancer mutations, 
perceived risk and attitudes towards hereditary breast cancer mutations were not significant 
predictors of intention for young African American women that participated in this current study 
(Jones et al., 2017; Kessler et al., 2005).  These findings suggest that there are potentially other 
important factors that were not included in this present study, such as cost, accessibility, and 
confidence in the accuracy of testing. Future research should explore other factors and how they 
can be best targeted and incorporated in behavioral interventions and public health campaigns.  
Limitations 
 One limitation of this current study is that this was a highly educated sample with 62 
percent of the sample having at least attended some college. Therefore, these findings may not be 
reflective of the experiences of individuals who have not attended college.  Another limitation is 
that the survey sample is limited to individuals who are signed up to participate in online surveys 
distributed by Qualtrics. As a result, findings may not represent the experiences of young African 
American women in the general population or those with limited access to the internet. Future 
research should include non-college attending young African American women as well as young 
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African American women in the general population to understand if the factors that influence 
their intentions to participate in potential PWT are different from the women who participated in 
this study. Another limitation of this study was that the dependent variable, intention to 
participate in PWT, was not normally distributed. The majority of responses to the intentions to 
participate in PWT item was unsure. The non-normal distribution of the dependent variable may 
impact the significance of the findings from this study given the potential impact of non-
normality on estimates of confidence intervals and standard errors in regression.  
Conclusion  
The potential for population-wide testing for hereditary breast cancer mutation could 
serve as a pathway to breast cancer prevention for young African American women and reducing 
existing breast cancer disparities. However, young African American women will not reap 
preventive benefits of participation in a potential initiative if the factors that may influence their 
intentions (attitudes and environmental constraints) are not understood prior to the 
implementation of such a service. Without fully understanding these factors, the implementation 
of such an initiative will only lead to the widening of existing disparities in the utilization of 
genetic counseling and testing and subsequently increase disparities in breast cancer incidence 
and mortality.  
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Chapter 4 
Introduction 
 
 There is a long-standing delay in the translation of academic research findings into public 
health practice. Balas & Boren (2000) found that it takes 17 years on average for research 
evidence to make its way into practice (Balas & Boren, 2000).  Most public health researchers 
and academics disseminate their findings primarily to academic journals. Journal publications 
carry a significant weight for academic researchers while they are on the job market and during 
the tenure and promotion process (Moore, Maddock, & Brownson, 2018). While worthwhile, 
this siloed dissemination strategy continues to contribute to significant lags in the sharing of 
evidence-based public health knowledge to key non-academic stakeholders, which includes 
public health practitioners, policy makers, and the community at large. Without academic 
researchers putting forth substantial efforts to utilize alternative dissemination strategies, public 
health research findings will continue to have challenges reaching non-academic audiences. 
Recent research has found that academic researchers are making efforts to close the translation 
gap. For example, a recent survey has indicated that approximately 58 percent of public health 
researchers associated with either federal agencies or universities disseminated their findings to 
local state health departments in the U.S (McVay, Stamatakis, Jacobs, Tabak, & Brownson, 
2016).  
 Non-academic stakeholders experience barriers to both accessing and understanding 
research findings presented in peer-reviewed journals (Brownson, Eyler, Harris, Moore, & 
Tabak, 2018).  Public health practitioners at local, state, and federal health departments 
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specifically lack access to journal articles, time, resources, and have the potential for information 
overload (Brownson et al., 2018). In turn, this leads to missed opportunities to use these findings 
to design evidence-based public health promotion programming and research, implement public 
health policies, as well as promote health behaviors to the general public.  
 Efforts to close the translation gap between academic researchers and non-academic 
audiences have taken different forms. More recently, academic researchers have disseminated 
public health research findings to the general public using more accessible formats including 
social media posts and websites, photovoice, and the creation of data briefs. (Brownson et al., 
2018). Data brief reports, in particular, provide the opportunity for the researcher to disseminate 
research findings in an abbreviated format that also utilizes graphs and tables to illustrate study 
findings (Brownson et al., 2018). For example, the Center for Disease Control and Prevention 
has utilized data brief reports to disseminate findings from current public health topics ranging 
from suicide rates to racial and ethnic disparities in infant mortality rates ("NCHS Data Briefs ", 
2018). Briefs are created with the intent of targeting a specific population which can range from 
the general public to public health practitioners (Brownson et al., 2018).  This current paper 
introduces a data brief entitled, “Population-wide testing for Hereditary Breast Cancer Genes: 
Recommendations for Public Health Practitioners to Reach and Raise Awareness Amongst 
Young African American women.” The target audience of this data brief are public health 
practitioners working in local or state health departments with disproportionate breast cancer 
burden amongst African American women. Public health practitioners working in these settings 
are particularly important because they are tasked with creating health promotion programming 
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and campaigns, connecting community members with health services, creating community 
partnerships, and ensuring that the health workforce is skilled and competent (Stover & Bassett, 
2003). Furthermore, these public health practitioners are responsible for operationalizing 
academic research findings into practice (Stover & Bassett, 2003).  Therefore, if PWT is 
implemented in the future, public health practitioners serving in local and state health 
departments in states with breast cancer disparities impacting African American women will 
need to have concisely presented recommendations to reach and raise awareness around PWT in 
this group.  African American women in Virginia, specifically, are diagnosed at higher rates, 
more advanced breast cancer stages, and are more likely to die from breast cancer than White 
women (Health, 2016 ). Due to these existing breast cancer disparities in Virginia, this data brief 
will be provided to stakeholders in both the Office of Health Equity and the Cancer Division at 
the Virginia Department of Health. Furthermore, this data brief will be disseminated on the 
Black Ladies In Public Health Facebook group that consists of over 10,000 African American 
women who are public health practitioners in various organizations and health departments 
across the country.  
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RECOMMENDATIONS FOR 
RAISING AWARENESS 
ABOUT POPULATION-
WIDE TESTING AMONG 
YOUNG AFRICAN 
AMERICAN WOMEN 
 
• Develop health promotion programs 
that include members of young 
African American women’s social 
networks such as events that focus on 
mothers and daughters. 
 
• Create public health campaigns that 
display mothers or friends providing 
information about the new initiative 
and speaking favorably of 
participation in testing.  
 
• Use targeted social media platforms          
        to communicate health     
        communication messages to young   
        African American.  
 
• Partner with Black breast cancer 
organizations.  
 
• Train healthcare workers to increase 
their cultural competency and 
improve patient-provider 
communication with young African 
American women patients.  
 
 
 
 
 
Public health practitioners working at local and state health 
departments are perfectly positioned to target and raise 
awareness about population-wide testing for hereditary breast 
cancer mutations. Currently, population-wide testing is a 
prospective future initiative that is garnering a lot of attention. 
The decreasing cost of genetic testing may make this a possible 
reality in the near future. Therefore, it is imperative to 
proactively provide public health practitioners with 
recommendations for potential programming, training, and 
public heath campaign strategies to reach young African 
American women, a group that is disproportionately impacted 
by breast cancer. Recommendations provided in this brief are 
based upon a research study that used focus groups and surveys 
with young African American women, ages 18-30 years, who 
are approaching the proposed screening age for population-
wide testing.  
What is population-wide testing?  
Population-wide testing would allow all women, regardless of 
their personal or family history of breast cancer, to utilize 
genetic counseling and testing services for hereditary breast 
cancer mutations.  This initiative is being proposed for all 
women in the United States beginning at age 30 (King, Levy-
Lahad, & Lahad, 2014; Pal et al., 2015). Currently, only 
women with a certain family or personal history of breast 
cancer can be recommended for genetic tests (NCCN, 2018). 
However, this approach typically leads to women lacking an 
understanding of their increased susceptibility for breast cancer 
until they have already been diagnosed (Jones et al., 2016; King 
et al., 2014). The goal of population-wide testing would be to 
create a pathway to breast cancer prevention.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Why is targeting young African American 
women important?  
 
Breast cancer is the second leading cause of cancer death for all 
women in the U.S (DeSantis et al., 2019). Young African 
American women are most likely to die from breast cancer and to 
be diagnosed with more aggressive forms of breast cancer 
(DeSantis et al., 2019). Moreover, young African American 
women breast cancer survivors have a high rate of hereditary 
breast cancer mutations, which substantially increase a women’s 
risk for breast cancer over her lifetime (Anders, Johnson, Litton, 
Phillips, & Bleyer, 2009; Pal et al., 2015). However, African 
American women utilize genetic counseling and testing for 
hereditary breast cancer at lower rates than White women 
(Armstrong, Micco, Carney, Stopfer, & Putt, 2005; Jones et al., 
2016). To address these disparities, it is critical that future 
programming, trainings, and public health campaigns are 
designed with young African American women in mind.  
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What do young African American women currently know 
about heredity breast cancer? 
 
 
• Young African American women have a limited to moderate knowledge of hereditary 
breast cancer mutations.  
 
 
 
 
"I haven't heard much of it, honestly. I just know that breast cancer can sometimes be 
hereditary in your family and some family members take precautions with their children at 
young ages to make sure that they don't go through that." – Focus Group Participant 
 
 
 
  
 
• Only 30 percent of participants knew that a woman with a sister with the gene did 
not have only a 1 in 4 chance of having the mutation herself.   
 
• 50 percent of participants knew that women who test positive for breast cancer 
gene mutations are more likely to develop breast cancer at an early age.  
 
• Nearly 69 percent of survey participants knew that 50 percent of inherited genetic 
information is passed down from a person’s mother. 
 
 
 
• Young African American women are aware that women in their racial/ethnic group 
have a heightened risk for more aggressive forms of breast cancer.  
 
 
 
"And so, I do know that black, well this might be incorrect, but black 
women can get some of the most aggressive forms of breast cancer." – 
Focus Group Participant 
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What are young African American women’s preferences for 
information sources about population-wide testing? 
 
 
 
Who: Young African American women want to receive information about 
population-wide testing from their mothers, breast cancer survivors, and other 
people that they trust including friends, relatives, and co-workers. They also 
want to hear from health care professionals, including OBGYNs, primary care 
providers, and nurses. 
 
 
“I mean, my mom has a lot more knowledge than I do                    
because she actually had to go through and experience, she 
actually had to get a mastectomy. So, I feel like I would go to her 
first because she knows." - Focus Group Participant 
 
 
 
How: Social media platforms including, Instagram, Facebook, and Twitter would 
all be important information sources about population-wide testing.    
 
 
 
 
 
 
"Social media, for sure. I mean, it's a huge platform already; use 
it to your benefit. I think that social media probably takes up the majority 
of most people's time, so definitely social media and using that as a 
mechanism to communicate not only the importance of it, but the 
accessibility of it and how to get it done."- Focus Group Participant 
 
 
 
 
 
 
 
 
 
 
 
94 
Recommendations for Programming and Public Health 
Campaigns for Population-wide Testing 
 
Public health practitioners working at local and state health departments are in a 
unique position to develop and implement health promotion programming, 
clinician trainings, and public health campaigns, and to partner with community 
organizations in their area to promote awareness about this potential initiative. 
 
Programming for Young African American Women 
 
 
• Create programming that includes not only young African American 
women, but also their mothers, other relatives, and peers. Providing 
educational programming for multiple members of their social networks 
could help to encourage additional conversations with these trusted 
information sources.  
 
• Seek out partnerships with local African American breast cancer organizations when 
creating programs for this initiative. African American breast cancer survivors could help 
bring additional legitimacy through their sharing of personal breast cancer experiences to the 
severity of breast cancer amongst Black women.  
 
Training for Healthcare Providers  
 
• Create trainings for healthcare providers that raise awareness about hereditary breast cancer 
mutations and their impact on racial minorities. Highlight the disparities in knowledge gaps 
around hereditary breast cancer mutations and tendencies to refer African American women for 
testing at lower rates than White women.  
• Increase cultural competency and patient-provider communication to address medical 
mistrust and facilitate provider conversations with young African American women.   
 
Public Health Campaigns 
 
• Develop health communication campaigns with scenarios displaying mothers or 
friends providing information about the potential new initiative and speaking 
favorably of participation in the service. 
• Disseminate information about population-wide testing on popular social media platforms. 
Partner with well-known African American influencers, who young African American women 
follow to provide them with information about population-wide testing.  
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Data Sources and Methods 
 
Recommendations presented in this brief report are based on focus group and surveys with 209 
young African American women between the ages of 18 and 30. Seven focus groups were 
conducted with 39 African American women who were either enrolled at one of two local 
colleges, Virginia Commonwealth University and Virginia Union University, or who were 
community residents in the Greater Richmond area. The majority were unmarried (94.9%), 
employed full-time (76.9%), were enrolled in college (64%), and did not have a family history 
of breast cancer (53.8%). Findings from this focus group were used to create a survey that was 
distributed to a larger online sample via Qualtrics Online Sample (n=170). Results from this 
study may not represent young African American women who do not participate in Qualtrics 
panels and more specifically, young women who have limited access to the internet. 
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                                                                   Chapter 5 
Discussion   
Population-wide testing (PWT) could be a significant pathway to breast cancer 
prevention for young African American women. Preemptively exploring their perspectives 
towards PWT is an important first step towards ensuring that existing breast cancer and genetic 
testing utilization disparities are reduced if PWT is implemented in the future. Therefore, the 
purpose of this dissertation was to conduct a sequential exploratory mixed methods study to 
preemptively understand young African American women’s (ages 18-30) perspectives and 
contributing factors towards hereditary breast cancer mutations and intended use of PWT if it 
were to be implemented in the future. The two main aims guiding this study were: 1) identify 
young African American women’s knowledge gaps and attitudes towards genetic counseling and 
testing as well as direct to consumer testing (DTC); assess motivators and barriers to 
participating in PWT and determine health communication preferences for PWT for hereditary 
breast cancer mutations; and 2)  examine the factors that influence young African American 
women’s intentions to participate in PWT for hereditary breast cancer mutations.  
Study findings were presented in the form of two manuscripts intended for peer review 
and a data brief aimed at public health practitioners at local and state health departments in urban 
cities with disproportionate breast cancer burden amongst African American women. The first 
paper presented findings from the focus groups conducted as a part of Aim 1 by examining 
young African American women’s perspectives towards PWT. The second paper presented the 
survey findings and explored factors that influence intentions to participate in PWT for 
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hereditary breast cancer mutations. This study had eight main hypotheses that explored the 
influence of multiple factors (i.e. attitudes towards DTC, subjective norms, group-based medical 
mistrust, individual medical mistrust, perceived risk, perceived severity, and perspectives 
towards hereditary breast cancer mutation) on intentions to participate in PWT. The third paper 
was presented in the format of a data brief and included health communication-related findings 
from both Aims 1 and 2. Specifically, the brief presented recommendations for public health 
practitioners working at local and state health departments to best reach and raise awareness 
amongst young African American women about the new initiative. Taken together, this 
formative study provides insight into existing knowledge gaps and attitudes that can inform 
future public health campaigns, behavioral interventions, clinician trainings, and breast cancer 
prevention programming with young African American women.  
 Knowledge about hereditary breast cancer mutations varied between the focus groups and 
surveys. While the majority of focus group participants expressed having limited to no 
knowledge about hereditary breast cancer mutations, survey respondents indicated moderate 
knowledge. Survey findings are consistent with a prior study which found that younger age was a 
significant predictor of greater knowledge about hereditary breast cancer mutations amongst 
African American breast cancer survivors at high risk for the mutations (Hurtado-de-Mendoza, 
Jackson, Anderson, & Sheppard, 2017). Differences in study findings could be due to the open-
ended way in which the question was asked in the focus group setting versus the true/false 
knowledge scale that was used in the survey. Another potential explanation is that the survey 
captured a larger sample, therefore ultimately providing insights about the knowledge level of a 
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larger sample. Knowledge is a particularly important indicator in that it has been found to predict 
genetic counseling and testing utilization amongst African American women (Hurtado-de-
Mendoza et al., 2017). Therefore, this current study suggesting that participants have limited to 
moderate knowledge about hereditary breast cancer mutations may indicate the need for more 
specific education in this group.  
 Medical mistrust was a common thread in the focus groups and survey data. Overall, 
participants indicated that they had moderate to high levels of medical mistrust. In the focus 
groups, medical mistrust was a commonly cited disadvantage and barrier to participation in DTC 
testing, the current model of genetic counseling and testing, as well as PWT. Consistent with 
prior research (Adams, Christopher, Williams, & Sheppard, 2015; Sheppard et al., 2014; 
Sheppard, Mays, Tercyak, & LaVeist, 2013), participants were keenly aware of the differences in 
quality of care, potential exploitation by the medical field, as well as had concerns about the 
confidentiality of testing results. When asked specifically about PWT, participants indicated that 
more research would be needed for them to be comfortable with participating in PWT.  High 
levels of medical mistrust might be attributed to mainstream conversations about Black maternal 
mortality, for example, in 2018, the near death experience during childbirth by top tennis player, 
Serena Williams due to her doctor not listening to her concerns (Haskell, 2018). Despite study 
participants high levels of medical mistrust, this variable was not associated with intentions to 
participate in PWT. This finding is particularly important given that medical mistrust has 
consistently been found to be a significant barrier to utilization of genetic counseling and testing 
amongst African American women at high risk for being a mutation carrier (Sheppard et al., 
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2013). Findings from this current study suggest that even though participants may have high 
levels of medical mistrust, it may not have the same impact on their intentions to participate in 
PWT.  
Cost was another commonly cited barrier to participation in all three genetic testing 
services explored in the focus groups. Cost has been consistently cited as a common barrier to 
African American women’s participation in traditional genetic testing (Adams et al., 2015; 
Sheppard et al., 2014). In this study, participants were not only concerned about the affordability 
of testing for themselves but were also more broadly hyperaware of potential disparities in access 
to testing for underrepresented minorities and socio-economically disadvantaged groups.  
Focus group participants indicated several benefits and motivators to participating in 
DTC testing, the current model of genetic testing, and PWT. Similar to prior studies that explore 
African American’s perspectives towards DTC testing (Carroll et al., 2019; Landry et al., 2017), 
participants indicated  that DTC testing was beneficial for learning more about ancestry and 
about personal risk for disease. Perhaps indicating the proliferation of direct to consumer testing, 
among survey participants, motivations to participate in direct to consumer testing was 
associated with intentions to participate in PWT. Similar to other research, advantages of the 
current model of genetic testing in a prior study (Adams et al., 2015), such as early detection, 
being informed, and the opportunity to make lifestyle changes, were also expressed by focus 
group participants. There was no association between participants’ attitudes towards hereditary 
breast cancer mutations and intentions to participate in PWT, despite perceived benefits of 
genetic counseling and testing being a predictor of genetic counseling and testing utilization in a 
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prior study with older African American women at high risk for a hereditary breast cancer 
mutation (Jones, McCarthy, Kim, & Armstrong, 2017). When focus group participants were 
asked about potential motivators to participate in PWT, they cited common motivators such as 
having children and a family history of breast cancer that may put them at high risk (Adams et 
al., 2015).  Furthermore, given the distrust of the medical field, participants noted the importance 
of access to quality healthcare as a motivator to participate in the potential new initiative.   
 In the survey, we explored the impact of subjective norms, perceived severity, and  
perceived risk on intentions to participate in PWT. Different from a prior study found that 
subjective norms did not influence genetic testing amongst African American women who had 
been diagnosed with breast cancer at a young age (Jones et al., 2016), this current study found 
that subjective norms was a significant predictor of intentions to participate in PWT. Differences 
between this current study may be due to the fact that participants in the prior study were 
diagnosed between the ages of 20-45 but participated in this study years later. Findings from this 
current study suggest that young African American women would be influenced by members of 
their social network including, family and friends, to participate in PWT.  Neither perceived risk 
for breast cancer nor perceived severity was associated with intentions among survey 
participants.   
Strengths, Limitations and Future Directions  
 This current study addresses a significant gap in the existing literature by exploring 
young African American women’s (18-30 years) perspectives about PWT and contributing 
factors that influence their intentions to participate in PWT. A strength of this study is that it 
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explores the perspectives of those who would be approaching the proposed screening age for 
PWT if it is implemented in the future.  The majority of existing studies have focused solely on 
those African American women who have a family or personal history suggestive of a hereditary 
breast cancer mutation (Hurtado-de-Mendoza et al., 2017; Jones et al., 2016; Sheppard et al., 
2014; Sutton et al., 2019).  There are limited studies on attitudes towards PWT  (Rubinsak et al., 
2019) and currently no studies that specifically focus on young African American women. 
Another strength of this study is that it used a sequential exploratory mixed methods study 
approach starting with qualitative research which allowed for an in-depth exploration of potential 
factors that were salient for this specific population and were then included in the larger survey. 
Lastly, the use of cognitive interviews was another strength of this current study given that they 
helped to increase the validity of the survey instrument prior to distribution.  
 However, there are a various limitations. Overall, this study may also not be 
representative of non-college attending and low income young African American women who 
may experience additional barriers, such as competing priorities and lack of employment-based 
health insurance, that may impact intentions to participate in PWT for hereditary breast cancer 
mutations. Another limitation of this study was that the dependent variable, intention to 
participate in PWT, was not normally distributed. The majority of women indicated that they 
were unsure about their intentions to participate in PWT. Future studies should be conducted 
with low income and non-college attending young African American women to explore whether 
their knowledge of hereditary breast cancer mutations, attitudes, and motivators and barriers to 
participating in PWT differ from the study participants.   
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 There are several other potential research directions that could stem from this research. 
Family and peer interventions could be beneficial in this group given the influence they have on 
participants intentions to participate in PWT. Furthermore, health communication related 
findings from this study suggest that interventions on social media platforms, such as Twitter and 
Instagram, may be well-suited for this group. Additional research should also determine what 
other factors may influence intentions to participate in PWT. Other factors that may be important 
for this group include, genetic counseling and the testing experience, preference for the type of 
medical professional providing the testing, and accessibility of testing, all of which may impact 
intentions to participate in PWT. Future research should focus on testing interventions with 
clinicians including primary care physicians and gynecologists, to not only raise knowledge 
about hereditary breast cancer mutations but also to improve their health directed messaging with 
young African American women. It will also be important for future research efforts to prioritize 
African American women who are older than 30 who may also be able to utilize PWT as a 
pathway to breast cancer prevention given that African American women shoulder a 
disproportionate burden of breast cancer mortality at every age (DeSantis et al., 2019). Lastly, 
African American women’s perspectives of PWT as it relates to ovarian cancer should be 
explored given that hereditary breast cancer mutations also substantially heighten a woman’s risk 
for ovarian cancer over her lifetime (Srivastava et al., 2017). Moreover, similar to existing breast 
cancer disparities, African American women tend to be diagnosed with ovarian cancer at more 
advanced stages and have higher mortality rates than White women (Srivastava et al., 2017).  
Implications for Practice  
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  There are several implications of this research for practice that can be implemented by 
public health practitioners.  First, is the use of social media as a strategy to develop targeted 
public health campaigns about PWT. Social media has become an integral part of the everyday 
lives of many individuals and is increasing becoming a significant source of health-related 
information (Li, Wang, Lin, & Hajli, 2018; Zhou, Zhang, Yang, & Wang, 2018). For example, 
the social media platform, Instagram, is a prime source for disseminating public health 
campaigns because users typically represent diverse socio-economic backgrounds and tend to be 
younger (Perrin & Anderson, 2019). Black users worldwide represent a greater percentage of 
Instagram users than Whites (Perrin & Anderson, 2019). Despite the potential utility of social 
media platforms, prior studies have consistently found that public health organizations  
underutilize socials media as a conduit of health communication (Basch & MacLean, 2019; 
Miller, Guidry, & Fuemmeler, 2019). Second, potential health promotion strategies might 
include partnerships with influencers on both Twitter and Instagram. Partnerships with popular 
influencers that have a large following on social media may provide an entryway for public 
health messages about such an initiative using popular hashtags, such as #BlackTwitter that have 
the potential to quickly circulate information to members of the African American community. 
Public health campaigns on both social media and traditional platforms will need to not only 
target young African American women but also members of their social network and will need to 
emphasize the importance of key members of their social network, such as parents and friends. 
 This study also has implications for public health programming. Similar to public health 
campaigns, findings suggest that it may be beneficial to create programming that targets not only 
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the young woman but also key social network members. One example of potential programming 
could be a mother- daughter event that increases awareness amongst the dyad about PWT. The 
goal of this type of programming would be to spark additional conversations after the event 
about the importance of PWT. Study findings suggest that it may be important to partner with 
Black breast cancer organizations to create programming. These organizations are regarded as 
highly credible and their support may enhance the importance of breast cancer prevention efforts, 
such as PWT, amongst young African American women.  
 Findings also suggest that it may be important to develop trainings for healthcare 
providers in an effort to help promote the participation of young African American women 
patients in PWT. Given that healthcare professionals lack knowledge about hereditary breast 
cancer mutations (Christensen et al., 2016; Hauser, Obeng, Fei, Ramos, & Horowitz, 2018), it 
may be important to develop trainings to increase knowledge about hereditary breast cancer 
mutations and PWT among these professionals.  Furthermore, additional training focusing on 
both cultural competency and patient-provider communication could be beneficial to assuaging 
medical mistrust amongst young African American women.  
Conclusion 
 PWT for hereditary breast cancer mutations for all women beginning at age 30 has been 
proposed as a viable potential pathway to breast cancer prevention for all women (King, Levy-
Lahad, & Lahad, 2014).  This was the first study to preemptively explore young African 
American women’s perspectives and intentions to participate in PWT.  Findings from this study 
provide insights about young African American women’s current knowledge gaps about 
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hereditary breast cancer mutations, potential motivators, and barriers to their participation in 
PWT, and recommendations for future research and practice. Ultimately, if PWT is 
implemented, preemptively prioritizing this group will be imperative to reducing existing breast 
cancer disparities impacting young African American women.  
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Appendix 1: Chapter 2 
 
 
Recruitment Email  
 
To whom it may concern,  
 
My name is Alesha Henderson and I am a doctoral candidate in the Department of Health 
Behavior and Policy at Virginia Commonwealth University. I am writing to invite you to 
participate in a research study that focuses on young African American women’s perspectives of 
hereditary breast cancer mutations and their health communication preferences.  This study calls 
for the participation of African American women between the ages of 18 and 30 from the Greater 
Richmond Area.  
 
Participation in this study involves:  
 
• Answering questions about hereditary breast cancer mutations and health communication 
preferences  
• 60-minute focus group in a private room on VCU’s campus or at a library in the Greater 
Richmond Area 
• Compensation will be provided  
 
 
If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304 
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the 
Department of Health Behavior and Policy at Virginia Commonwealth University.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Social media recruitment  
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Research study about Hereditary Breast Cancer Mutations and 
Health Communication Preferences 
 
Purpose: We want to examine young women’s perspectives about hereditary breast cancer 
mutations and potential population-wide testing for hereditary breast cancer mutations.  
 
We are looking for young African American women to participate in a focus group.  
 
 
Who can participate?  
 
• African American women in the Greater Richmond Area between the ages of 18 and 30.  
 
What does participation involve?  
• Answering questions about hereditary breast cancer mutations and health communication 
preferences  
• 60-minute focus group in a private room on VCU’s campus or at a library in the Greater 
Richmond Area 
• Compensation will be provided  
 
If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304 
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the 
Department of Health Behavior and Policy at Virginia Commonwealth University.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
 
 
Eligibility Screening for Focus Groups 
 
1. Do you identify as Black or African American women?  □ Yes □ No 
2. Are you between the ages of 18 and 30 years old?   □ Yes □ No 
a.   If so, what is your age? _________ 
3. Do you live in the Greater Richmond Area?  
                        □ Yes  □ No 
a.  If yes, what is your city and county of residence?  
_____________________________________________________________ 
4.  Do you have a known hereditary breast cancer mutation?  
                                              □ Yes  □ No 
5.         Are you currently enrolled at Virginia Commonwealth University?  
                                              □ Yes  □ No 
a. If yes, what degree program are you pursuing?   
___________________________________________________ 
 
6.        Are you currently enrolled at Virginia Union University? 
                            □ Yes  □ No 
a. If yes, what degree program are you pursuing?   
        _____________________________________________________ 
 
 
 
 
 
 
 
 
 
RESEARCH PARTICIPANT INFORMATION SHEET 
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TITLE: Changing Landscapes: Perspectives of Young African 
American women of Population-Wide Testing for Hereditary Breast 
Cancer Mutations 
 
VCU IRB NO.: HM20015881 
 
PRINCIPAL INVESTIGATOR: Alesha Henderson, M.A. 
Department of Health 
Behavior & Policy Virginia 
Commonwealth University 
Phone: 804-614-8304 
Email: 
Hendersonan2@mymail.vcu.edu 
 
Maghboeba Mosavel, PhD 
Department of Health 
Behavior & Policy Virginia 
Commonwealth University 
Richmond, Virginia 23298-
0149 
Phone: (804) 628-2929 
Fax: (804) 828-5440 
PURPOSE OF THE STUDY 
 
You are being invited to participate in this research study about population-wide testing for 
hereditary breast cancer mutations and your health communication preferences. The results of 
this study will be used to develop a survey that will be distributed to a larger sample of young 
African American women. In this study, you will be asked to visit a conveniently located room 
at a library in the Greater Richmond Area or on Virginia Commonwealth University’s campus 
to participate in a 60-minute focus group about hereditary breast cancer mutations and health 
communication preferences. 
 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 
Your participation in this research study is voluntary. You do not have to participate in this 
study. If you choose to participate, you may stop at any time without any penalty. You may also 
choose not to answer particular questions that are asked in the study. Discontinuing your 
participation or withdrawing from the study will not result in any loss or benefits to which you 
are otherwise entitled. If you decide to join the study, you may withdraw at any time and for 
any reason without penalty or loss of benefits. 
 
 
 
 
 
 
 
 
114 
 
RISKS AND DISCOMFORTS 
 
There are minimal risks associated with participation in this study. Questions posed in the 
focus groups should not cause any distress to you given that they are not personal in nature but 
if they do, you can choose to skip any question that you do not feel comfortable with and can 
discontinue your participation in this study at any time. There is also a risk of a loss of 
confidentiality or privacy. Other members of the focus groups will be able to see that you are 
in the study and hear your responses, but we will not share any other information you provide 
to us with other members of the group. 
 
 
PAYMENT FOR PARTICIPATION 
 
As a display of our appreciation for your participation in this study, you will receive a $15 
gift card when you complete the focus group. 
 
 
QUESTIONS 
 
If you have any questions, concerns, or complaints about this study now or in the future, please 
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu. 
She is currently a doctoral candidate in the Department of Health Behavior and Policy at 
Virginia Commonwealth University. 
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Appendix 2 Chapter 3 
 
 
 
 
 
Research study about Hereditary Breast Cancer Mutations and 
Health Communication Preferences 
 
Purpose: We want to get young African American women’s feedback on a survey that will be 
distributed to a larger sample of young African American women.   
 
We are looking for young African American women to participate in an interview.  
 
 
Who can participate?  
 
• African American women between the ages of 18 and 30 who are community residents in the Greater 
Richmond Area.  
 
AND 
  
• African American women between the ages of 18 and 30 that attend Virginia Commonwealth 
University or Virginia Union University 
 
What does participation involve?  
• Participating in a 60 minute telephone interview  
• Review an online survey on your cellphone or computer  
• Providing feedback on its’ design and questions  
• Incentives will be provided.  
 
 
If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304 
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the 
Department of Health Behavior and Policy at Virginia Commonwealth University.  
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To whom it may concern,  
 
My name is Alesha Henderson and I am a doctoral candidate in the Department of Health 
Behavior and Policy at Virginia Commonwealth University. I am writing to invite you to 
participate in a research study that focuses on young African American women’s perspectives 
of hereditary breast cancer mutations and their health communication preferences.  This study 
calls for the participation of African American women between the ages of 18 and 30 from the 
Greater Richmond Area. We are specifically looking for students enrolled at either Virginia 
Commonwealth University or Virginia Union University. African American women between the 
ages of 18 and 30 who are community residents in the Greater Richmond area are also eligible 
to participate.  
 
Participation in this study involves:  
 
• Participating in a 60 minute telephone interview ($10 gift card for participation)  
• Review an online survey on your cellphone or computer  
• Providing feedback on its’ design and questions  
 
 
 
If you are interested in participating in this study, please call Alesha Henderson at 804-614-8304 
or email her at hendersonan2@mymail.vcu.edu. She is currently a doctoral candidate in the 
Department of Health Behavior and Policy at Virginia Commonwealth University.  
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Eligibility Screening for Cognitive Interviews 
 
1. Do you identify as Black or African American women?  □ Yes □ No 
2. Are you between the ages of 18 and 30 years old?   □ Yes □ No 
           a.   If so, what is your age? _________ 
 
3. Do you live in the Greater Richmond Area?  
                        □ Yes  □ No 
a.  If yes, what is your city and county of residence? 
_____________________________________________________________ 
 
4.  Do hereditary breast cancer mutations run in your family?  
                                              □ Yes  □ No 
5.         Are you currently enrolled at Virginia Commonwealth University?  
                                              □ Yes  □ No 
 
a. If yes, what degree program are you pursuing?   
_________________________________________________________________________ 
 
6.        Are you currently enrolled at Virginia Union University? 
                            □ Yes  □ No 
a.       If yes, what degree program are you in?  
 
7, Do you have access to the internet via either a cellphone or computer?  
                            □ Yes  □ No 
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RESEARCH PARTICIPANT INFORMATION SHEET FOR VERBAL CONSENT 
 
TITLE: Changing Landscapes: Perspectives of Young African American women of Population-
Wide Testing for Hereditary Breast Cancer Mutations 
 
VCU IRB NO.: HM20015881 
 
PRINCIPAL INVESTIGATOR:                                  Alesha Henderson, M.A. 
Department of Health 
Behavior & Policy Virginia 
Commonwealth University 
Phone: 804-614-8304 
Email: Hendersonan2@mymail.vcu.edu 
 
Maghboeba Mosavel, PhD 
Department of Health 
Behavior & Policy Virginia 
Commonwealth University 
Richmond, Virginia 23298-
0149 
Phone: (804) 628-2929 
Fax: (804) 828-5440 
 
PURPOSE OF THE STUDY 
You are being invited to participate in this research study about population-wide testing for 
hereditary breast cancer mutations and your health communication preferences. The results of 
this study will be used to develop a survey that will be distributed to a larger sample of young 
African American women. In this study, you will be asked to participate in a 60-minute 
cognitive telephone interview to review provide feedback on an online survey. Interviews will 
be audio-recorded and transcribed so that they are accurately reported. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 
Your participation in this research study is voluntary. You do not have to participate in this 
study. If you choose to participate, you may stop at any time without any penalty. You may also 
choose not to answer particular questions that are asked in the study. Discontinuing your 
participation or withdrawing from the study will not result in any loss or benefits to which you 
are otherwise entitled. If you decide to join the study, you may withdraw at any time and for 
any reason without penalty or loss of benefits. 
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RISKS AND DISCOMFORTS 
 
There are minimal risks associated with participation in this study. The questions asked in this 
study should not cause any distress. However, in the case that you feel that you need mental 
health services, Therapy for Black Girls is a great online resource to find local therapy 
services provided by African American women. There are also mobile apps, such as 
Betterhelp and Talkspace, that provide online therapy services. 
 
PAYMENT FOR PARTICIPATION 
 
As a display of our appreciation for your participation in this study, you will receive a $10 gift 
card via mail after you complete the cognitive interview. 
 
QUESTIONS 
If you have any questions, concerns, or complaints about this study now or in the future, please 
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu. 
She is currently a doctoral candidate in the Department of Health Behavior and Policy at 
Virginia Commonwealth University. 
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Welcome and Introduction 
 
Hello! Welcome to today’s cognitive interview session and thank you for taking the time to be here with 
me. My name is Alesha Henderson and I will be conducting the interview today. I am a fourth-year, 
social and behavior sciences, doctoral candidate in the Department of Health Behavior & Policy in the 
School of Medicine at Virginia Commonwealth University.  
 
Purpose: I’ve invited you here today to ask you to complete a survey so that I can get your perspectives 
on a survey that will be distributed to other African American women between the ages of 18 and 30. The 
survey broadly focuses on your knowledge of and perspectives towards hereditary breast cancer 
mutations, potential population-wide testing for hereditary breast cancer mutations, and your health 
communication preferences for messages about population-wide testing.  
 
Process: I will ask you to respond verbally and on the online survey platform to questions from a 
previously developed online survey. There are no right or wrong answers to the questions that I ask you. 
After asking certain questions, I will ask you additional questions about your experience understanding 
and responding to the question. Again, there are no right or wrong answers. Your responses will help to 
create a better version of the survey to be distributed to a larger online sample.  
 
This session is expected to last no more than 60 minutes and you will receive  a $10 gift card for  
compensation for your participation at the end of the survey.  In-person participants will be handed their 
compensation upon completion of the interview. Individuals who participate in the second round of 
cognitive interviews will receive their compensation via mail. The session will be audio-recorded. The 
recordings will not contain any names or personal information and will only be used for research 
purposes. 
 
In Case of Distress: The interview questions are not specific to your personal lives; however, you may 
choose not to answer particular questions that are asked in the study. Your participation in this session is 
completely voluntary. If at any time you feel uncomfortable or distressed, please don’t hesitate to stop me 
at any time without any consequence. Also, please note that, for your safety, I will have to break 
confidentiality if you mention that you have been harmed, are harming oneself, or have/will harm(ed) 
others. As part of VCU’s policy and procedures, I will have to report this to the appropriate outlets.  
 
At this time, we ask that you please take a moment to read the informed consent document.  
 
 
 
 
 
 
Instructions for interviewer: 
à Current probing questions begin at the description of direct to consumer testing. 
(highlighted in red) 
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à There are interview instructions for each question ( highlighted in grey ) 
à Probes have been created and listed under each of the questions of interest (highlighted 
in yellow) 
à Be sure to go through each question with each cognitive interview participants 
 
 
Survey Begins Here:  
 
 
Survey Introduction: I am currently conducting research on the perspectives of young African 
American women between the ages of 18 and 30 on hereditary breast cancer mutations and the 
potential for population-wide testing for hereditary breast cancer mutations for all women in the 
United States among young women like yourselves. Questions will focus on your knowledge of 
and perspectives towards hereditary breast cancer mutations, potential population-wide testing 
for hereditary breast cancer mutations, and your health communication preferences for messages 
about population-wide testing. 
 
This survey should take approximately 20-25 minutes to complete.  
 
If you have any questions about the survey, please email Alesha Henderson at 
hendersonan2@vcu.edu.  
 
 
Direct To Consumer Testing: Direct-to-consumer genetic tests are marketed directly to 
customers via television, print advertisements, or the Internet, and the tests can be bought online 
or in stores. Customers send the company a DNA sample and receive their results directly from a 
secure website or in a written report. Direct-to-consumer genetic testing provides people access 
to their genetic information without necessarily involving a healthcare provider or health 
insurance company in the process (Retrieved February 4, 2020 from 
https://ghr.nlm.nih.gov/primer/dtcgenetictesting/directtoconsumer). 
 
Cognitive Interviewer questions start here!!!  
 
Question Instructions for Interviewers:  
 
Please Ask the following questions about the paragraph about direct to consumer testing above:  
 
1. Paraphrase: Would you please repeat that to me in your own words?  
 
2. Comprehension: What does the term “genetic test” mean to you?  
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3. Comprehension: What does direct to consumer testing mean to you?  
 
4. General probe: Was that easy or hard for you to read?  
 
 
1. Do you know or have you heard of genetic tests that are provided directly to consumers via the 
internet?  
a. Yes 
b.  No  
 
 
 
2. Have you ever done a genetic test which is provided directly to consumers via the internet?  
a. Yes  
b. No  
 
 
 
Below are several statements describing why some people may do direct to consumer genetic 
testing. Please indicate how much you agree each statement. For what reason/motivation 
would you do direct to consumer genetic testing? 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
 
 Strongly 
Disagree 
Disagree Neither 
Agree or 
Disagree 
Agree Strongly 
Agree 
3.  To know more about my health.  1 2 3 4 5 
4. So that the doctor can monitor my 
health.  
1 2 3 4 5 
5.  To change my lifestyle (e.g. 
dietary habits, exercise) in case the 
genetic test shows that I have an 
increased risk for a certain disease.  
1 2 3 4 5 
6.  To inform my children about their 
possible increased risk for a 
disease. 
1 2 3 4 5 
7.  Out of curiosity. 1 2 3 4 5 
8.  Out of scientific/ research interest  1 2 3 4 5 
9.  For fun.  1 2 3 4 5 
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1. Paraphrase: Would you please repeat the main question in your own words?  
 
2. General Probe: Can you take me through the steps of how you came to your answers for questions 12 
through 18?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
12-18.  
 
3. General probe: Were these questions easy or hard for you to answer?  
 
 
 
 
Below are several statements describing why some people may not do direct to consumer 
genetic testing. Please indicate how much you agree each statement. For what reason would 
you not like to do direct to consumer genetic testing?  
 
 
 
 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
 
1. Paraphrase: Would you please repeat the main question in your own words?  
 
2. General Probe: Can you take me through the steps of how you came to your answers for questions 19 
through 22?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
19-22.  
 
 Strongly 
Disagree 
Disagree Neither 
Agree or 
Disagree 
Agree Strongly 
Agree 
10.  The results are unreliable.   1 2 3 4 5 
11. The information will not be useful.   1 2 3 4 5 
12.  I wouldn’t like to know the risk I 
have to develop a certain disease.   
1 2 3 4 5 
13.  I worry about my personal data 
and private life.  
1 2 3 4 5 
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3. General probe: Was that easy or hard for you to answer?  
 
 
 
Question Instructions for Interviewers:  
 
Probe about both direct to consumer scales:  
 
4. General probe: Do you feel as if the description of direct to consumer testing provided sufficient 
information to answer those two questions?  
 
 
 
 
 
 
 
 
 
The next set of questions is to find out how much you may already know about genes for 
cancer.  
 
 
 True  False  Don’t know  
14. 50% (or half) of inherited genetic 
information (about breast cancer risk) is 
passed down from a person’s mother.  
01 02 3 
15. 25% of inherited genetic information (about 
breast cancer risk) is passed down from a 
person’s father.  
01 02 3 
16. There is more than one gene that can 
increase the risk of breast cancer.  
01 02 3 
17. A woman who has a sister with a breast 
cancer gene mutation has a 1 in 4 chance of 
having a gene mutation herself.  
01 02 3 
18. One in ten women has a breast cancer gene 
mutation.  
01 02 3 
19. Women who test positive for breast cancer 
gene mutations are more likely to develop 
breast cancer at a young age.  
01 02 3 
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20. If a woman tests positive for a breast cancer 
gene mutation, her male relatives’ risk for 
developing prostate cancer are lowered 
01 02 3 
21. A woman may be at a greater risk for 
developing ovarian cancer if she has several 
close relatives with breast cancer.  
01 02 3 
22. A woman who has her healthy ovaries 
removed will definitely not get ovarian 
cancer.  
01 02 3 
23. A woman who has her breasts removed will 
definitely not get breast cancer.  
01 02 3 
24. Screening for ovarian cancer often does not 
detect a tumor until it’s more advanced.  
01 02 03 
 
 
 
 
 
Genetic Counseling:  Genetic counseling is a communication process between a specially 
trained health professional and a person concerned about the genetic risk of disease. The person's 
family and personal medical history may be discussed, and counseling may lead to genetic 
testing.  
 
 
Question Instructions for Interviewers:  
 
Ask the following questions about the paragraph about genetic counseling above:  
 
1. General probe: Was that easy or hard for you to read?  
 
2. Comprehension: In your own words, what is genetic counseling?  
 
25. Have you ever heard about genetic counseling for hereditary breast cancer genes (e.g., Breast cancer 
gene)?  
a. Yes  
b. No (skip pattern here)  
 
26. If yes, how did you hear about genetic counseling for hereditary breast cancer genes (e.g.,  Breast 
cancer gene)? Please check all that apply:  
□ TV  
                  □ Newspaper  
                  □ Internet           
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      □ Friends  
                  □ Family  
                  □ Physician  
                  □ Other health professional: 
i.  Please specify __________________ 
 
27. Has your healthcare provider ever talked to you about genetic counseling for hereditary breast cancer 
mutations?  
a. Yes  
b. No (Skip pattern to Question 29)  
 
 
28. Did she/he give you a referral for genetic counseling?  
a. Yes  
b. No  
 
 
 
Genetic Testing: Genetic testing for hereditary breast cancer looks for a mutation in your genes. 
Genetic testing may or may not involve genetic counseling or meeting with a genetic counselor.    
 
 
Question Instructions for Interviewers:  
 
Ask the following questions about the paragraph about genetic testing above:  
 
1. General probe: Was that easy or hard for you to read?  
 
2. Comprehension: In your own words, what is genetic testing?  
 
 
 
29.  Have you ever heard about genetic testing for a hereditary breast cancer gene (e.g. BRCA)? 
a. Yes  
b. No (skip pattern to Question 31) 
 
 
30. If yes, how did you hear about genetic testing for hereditary breast cancer mutations? Please check all 
that apply:  
□ TV  
                  □ Newspaper  
                  □ Internet           
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      □ Friends  
                  □ Family  
                  □ Physician  
                  □ Other health professional: 
i.  Please specify _________________ 
 
 
 
 
 
The next questions focus on your perspectives of hereditary breast cancer mutations.  
 
 Strongly 
Disagree 
Disagree Neither 
Agree or 
Disagree 
Agree Strongly 
Agree 
31.  If I were found to carry the gene, 
it would help members of my 
family like daughter(s) or sister(s) 
decide whether to undergo genetic 
testing. 
1 2 3 4 5 
32.  Knowing that I carry the gene 
would help me decide whether to 
go for more frequent 
mammograms.  
1 
 
2 3 4 5 
33.  Knowing whether or not I carry 
the gene would increase my sense 
of personal control. 
1 2 3 4 5 
34.  Knowing that I do not carry the 
gene would greatly improve my 
quality of life. 
1 2 3 4 5 
35.  My concerns about developing 
breast cancer would be reduced if I 
knew I did not carry the gene. 
1 2 3 4 5 
36.  My concerns about developing 
breast cancer would increase if I 
knew that I carried the gene. 
1 2 3 4 5 
37.  Knowing that I do not carry the 
gene would not be helpful since I 
could still develop breast cancer. 
1 2 3 4 5 
38.  If I were found to carry the gene, 
it would jeopardize my insurance 
1 2 3 4 5 
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Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
  
 
1. General Probe: Can you take me through the steps of how you came to that answer for each of the 
perspectives towards hereditary breast cancer mutations listed in questions 40-52?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
in questions 40-52.  
 
2. General probe: Were questions 40-52 easy or hard for you to answer?  
 
3.  General probe: Do you feel as if the description of genetic counseling and testing provided sufficient 
information to answer this question?  
 
 
 
 
 
44.  How likely do you think it is that you carry a hereditary breast cancer mutation?  
a. Not at all likely  
coverage or lead to problems with 
my employers. 
39.  If I were found to carry the gene, 
it would cause others to view me 
negatively. 
1 2 3 4 5 
40.  If I were found to carry the gene, 
it would lead to marital or family 
problems. 
1 2 3 4 5 
41.  Testing is not worthwhile because 
it could yield inconclusive results 
about whether I carry the gene for 
breast cancer. 
1 2 3 4 5 
42.  If I were found to carry the gene 
for breast cancer, I would worry 
about passing the gene to my 
children. 
1 2 3 4 5 
43.  If I were found to carry the gene, I 
would worry that the results would 
not stay confidential. 
1 2 3 4 5 
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b. Somewhat likely  
c. Likely  
d. Very Likely  
e. Extremely likely 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions about the question above:  
 
1. Paraphrase: Would you please repeat the question that I just asked you in your own words?  
 
2. General Probe: Can you take me through the steps of how you came to that answer?  
 
3. Specific Probe: Do you think it would be hard for other people to answer that question?  
 
  
 
 
The next set of questions ask you to imagine the reaction you would have if you were to be 
told you have a hereditary breast cancer mutation.  
 
 
 Strongly 
Disagree  
Disagree  Neither agree 
or disagree  
Agree  Strongly 
agree  
45. If I found out I carried a 
gene mutation, it would 
greatly disrupt my life.  
1 2 3 4 5 
46. Finding out I carried a 
gene mutation would be 
very difficult for me.  
1 2 3 4 5 
47. If I found out I carried a 
gene mutation, I would 
worry much more about 
developing breast cancer.  
1 2 3 4 5 
 
 
 
 
Question Instructions for Interviewers:  
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Please ask the following questions related to the scale above:  
 
1. General Probe: Can you take me through the steps of how you came to your answers for questions 54-
56?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
54-56.  
 
2. General probe: Were those questions easy or hard for you to answer?  
 
3. Specific Probe: Do you think it would be hard for other people to answer that question?  
 
 
 
 
 
 
When getting health care, have you ever had the following things happen to you because of 
your race or ethnicity? 
 
 Yes No Unsure  
48.  Been treated with less courtesy than other 
people. 
01 02 888 
49.  Been treated with less respect than other 
people. 
01 02 888 
50.  Received poorer service than others. 01 02 888 
51.  Had a doctor or nurse act as if he or she 
thinks you are not smart?  
01 02 888 
52.  Had a doctor or nurse act as if he or she is 
afraid of you? 
01 02 888 
53.  Had a doctor or nurse act as if he or she is 
better than you? 
01 02 888 
54.  Felt like a doctor or nurse was not listening 
to what you were saying? 
01 02 888 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
 
1. Paraphrase: Would you please repeat the main question in your own words?  
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2. General Probe: Can you take me through the steps of how you came to your answers for questions 57-
63?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
57-63.  
 
3. General probe: Was that easy or hard for you to answer?  
 
 
 
 
Thinking about the relationship between various racial/ethnic groups and the American 
medical system, please rate how strongly you agree or disagree with the following 
statements.  Please note, we are referring to your general feelings… 
 
 Strongly 
Disagree Disagree Neutral Agree 
Strongly 
Agree Unsure  
55. Doctors and health care 
workers sometimes hide 
information from patients 
who belong to my 
racial/ethnic group 
1 2 3 4 5 888 
56. Doctors have the best 
interests of people of my 
racial/ethnic group in mind 
1 2 3 4 5 888 
57. People of my racial/ethnic 
group should not confide in 
doctors and health care 
workers because it will be 
used against them 
1 2 3 4 5 888 
58. People of my racial/ethnic 
group should be suspicious 
(distrustful) of information 
from doctors and health care 
workers  
1 2 3 4 5 888 
59. People of my racial/ethnic 
group cannot trust doctors 
and health care workers  
1 2 3 4 5 888 
60. People of my racial/ethnic 
group should be suspicious of 
modern medicine 
1 2 3 4 5 888 
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61. Doctors and health care 
workers treat people of my 
racial/ethnic group like 
“guinea pigs” 
1 2 3 4 5 888 
62. People of my racial/ethnic 
group receive the same 
medical care from doctors 
and health care workers as 
people from other groups 
1 2 3 4 5 888 
63. Doctors and health care 
workers do not take the 
medical complaints of people 
of my racial/ethnic group 
seriously 
1 2 3 4 5 888 
64. People of my racial/ethnic 
group are treated the same as 
people from other groups 
1 2 3 4 5 888 
65. In most hospitals, people of 
different racial/ethnic groups 
receive the same kind of care 
1 2 3 4 5 888 
66. I have personally been 
treated poorly or unfairly by 
doctors or health care 
workers because of my 
racial/ethnic group. 
1 2 3 4 5 888 
 
 
 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
 
1. Paraphrase: Would you please repeat the main statement in your own words?  
 
2. General Probe: Can you take me through the steps of how you came to that answer for each of your 
potential race-based experiences listed in questions 64-75?   
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
64-75.  
 
3. General probe: Was that easy or hard for you to answer?  
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The next questions ask about the ways you may or may not have relied on religion to deal 
with life stressors.    
 
 
 
Not at all  Very little  Somewhat  
A great 
deal  
Not 
Applicable 
67. Looked for a stronger 
connection with God.  1 2 3 4 999 
68. Sought God’s love 
and care.  1 2 3 4 999 
69. Sought help from 
God in letting go of 
my anger.  
1 2 3 4 999 
70. Tried to put my plans 
into action together 
with God.   
1 2 3 4 999 
71. Tried to see how God 
was trying to 
strengthen me in this 
situation.   
1 2 3 4 999 
72. Asked forgiveness 
for my sins.  1 2 3 4 999 
73. Focused on religion 
to stop worrying 
about my problems.  
1 2 3 4 999 
74. Wondered whether 
God had abandoned 
me.  
1 2 3 4 999 
75. Felt punished by God 
for my lack of 
devotion.  
1 2 3 4 999 
76. Questioned God’s 
love for me.  1 2 3 4 999 
77. Wondered whether 
my church had 
abandoned me.  
1 2 3 4 999 
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78. Decided the devil 
made this happen to 
me.  
1 2 3 4 999 
79. Questioned the power 
of God.  1 2 3 4 999 
 
 
 
 
 
 
Population-based testing for hereditary breast cancer mutations:  There is a current proposal 
about to offer genetic counseling and testing for hereditary breast cancer mutations to all women 
in the United States starting at age 30. Please answer the next questions with this in mind.  
 
Question Instructions for Interviewers:  
 
Please ask the following questions about the paragraph above about population-based testing:  
 
1. General probe: Was that easy or hard for you to read?  
2. Comprehension: In your own words, what is population-based testing?  
 
 
 
80. Now try to imagine that you are offered genetic testing and counseling for breast cancer susceptibility 
through a population-based testing initiative at some point in the future, would you choose to have the 
test 
 
a. No, Definitely not (1) 
b. No, Probably not (2) 
c. Unsure (3) 
d. Yes, probably (4)  
e. Yes, definitely (5) 
 
Question Instructions for Interviewer:  
 
Please ask the following about the question above:  
 
1. Paraphrase: Would you please repeat the question in your own words? 
 
2. General Probe: Can you take me through the steps of how you came to that answer?  
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3. General probe: Was that easy or hard for you to answer? 
 
 
 
 
The next questions ask you to imagine what members of your social circle would think of 
you participating in population-based testing if it becomes available. 
  
 
 
Strongly 
Disagree 
Disagree Neither 
Agree/Disagree 
Agree Strongly 
Agree 
Unsure 
 
Not 
applicable  
81. My friends would 
approve of me 
getting genetic 
testing and 
counseling through 
population-based 
testing.  
01 02 03 04 05 888 999 
82. My spouse would 
approve of me 
getting genetic 
testing and 
counseling through 
population-based 
testing.  
01 02 03 04 05 888 999 
83. My parents would 
approve of me 
getting genetic 
testing and 
counseling through 
population-based 
testing.  
01 02 03 04 05 888 999 
84. My siblings would 
approve of me 
getting genetic 
testing and 
counseling through 
population-based 
testing.  
01 02 03 04 05 888 999 
85. My other family 
member would 
approve of me 
getting genetic 
01 02 03 04 05 888 999 
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testing and 
counseling through 
population-based 
testing.  
 
 
 
 
 
 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the scale above:  
 
1. Paraphrase: Would you please repeat the main statement in your own words?  
 
2. General Probe: Can you take me through the steps of how you came to your answers for questions 90-
94 ? 
 
a. Allow the respondent to provide their rationale/ decision making process for scale responses 
90-94.  
 
3. General probe: Was that easy or hard for you to answer?  
 
 
 
 
 
86. Would you be willing to pay out of pocket for genetic testing for breast cancer risk 
through population-based testing?  
□ Up to $50 (1) □ Up to $200 (3)    □ More than $500 (5) 
□ Up to $100 (2) □ Up to $500 (4) □ I would not be willing to pay any money (6) 
 
Question Instructions for Interviewers:  
 
Please ask the following questions related to the question above.  
 
1. Paraphrase: Would you please repeat the question in your own words? 
 
2. General Probe: Can you take me through the steps of how you came to that answer?  
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87. Imagine you had a strong need to get information about population-based testing for 
hereditary breast cancer mutations. Where would you go first to get information? (Mark 
only one) 
a. Printed materials (for example, newspapers, magazines)  
b. Health care provider (doctor, nurse, social worker)  
c. Conversations with people you trust (friends, relatives, or co-workers)  
d. Internet (Google or another search engine, WebMD or another medical website) 
e. Social Media (Facebook, Instagram, Twitter) 
 
88. Imagine you had a strong need to get information about population-based testing for 
hereditary breast cancer mutations. Which of the following would you most trust as a 
source of information about population-based testing for hereditary breast cancer 
mutations? (Mark only one)  
a. Printed materials (for example, newspapers, magazines)  
b. Health care provider (doctor, nurse, social worker)  
c. Conversations with people you trust (friends, relatives, or co-workers)  
d. Internet (Google or another search engine, WebMD or another medical website) 
e. Social Media (Facebook, Instagram, Twitter) 
 
Thanks for completing the survey. The next questions ask you to provide demographic 
information about yourself.    
 
Demographic Survey  
 
1. What is your age? _____  
 
2. Do you have a family history of breast cancer? 
a. Yes  
b. No  
 
3. Are you Hispanic or Latino?  
a. Yes, Hispanic or Latino  
b. Not, Hispanic or Latino 
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4. Please tell me which category best describes your racial background?  
                  a.    Black or African American  
      b.    White  
 
      c.   Asian 
      d. American Indian/ Alaskan Native  
      f.    Native Hawaiian or Other Pacific Islander (6) 
      g.   More than One Race  
      h. Other: please specify __________________  
 
 
5. What is your highest grade or level of schooling you have completed?  
a. Less than high school  
b. High School or general equivalency degree  
c. Some college or technical school  
d. Bachelor’s degree  
e. Graduate Degree  
 
6. Do you have health insurance?  
a. Yes  
b. No  
c. Not sure  
 
7. Do you have a regular physician or health care provider?  
a. Yes  
b. No  
 
8. What is your income?  
a. Less than $20,000 
b. $20,000-$39,999 
c. $40,000- $59,999 
d. $60,000- $79,999 
e. $80,000- $99,999 
f. $100,000- $119,999  
g. At least $120,000  
 
 
 
9. What is your employment status?  
a. Full-time  
b. Part-time  
c. Unemployed  
d. Retired  
e. Unable to work  
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f. Homemaker  
g. Student  
 
10. What is your marital status?  
a. Married  
b. Living Together  
c. Divorced  
d. Widowed  
e. Separated  
f. Never Married  
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Dissertation Survey 7.16 
 
 
Start of Block: Block 1 
 
Q30 What is your age?  
________________________________________________________________ 
 
Skip To: End of Block If Condition: What is your age?  Is Less Than 18. Skip To: End of Block. 
Skip To: End of Block If Condition: What is your age?  Is Greater Than 30. Skip To: End of Block. 
 
 
 
Q33 Please tell me which category best describes your racial background?  
o Black or African American (1)  
o White (2)  
o Asian (3)  
o American Indian/ Alaskan Native (4)  
o More than One Race (5)  
o Other: please specify (6) ________________________________________________ 
 
Skip To: End of Block If Please tell me which category best describes your racial background?  != Black or African 
American 
 
 
 
 
 
 
 
 
 
 
 
141 
Q41 What is your gender? 
o Male (1)  
o Female (2)  
o Other/Non-binary (3)  
 
Skip To: End of Block If What is your gender? != Female 
 
 
 
Q42 Do hereditary breast cancer mutations run in your family? 
o Yes (1)  
o No (2)  
o I don't know (3)  
 
End of Block: Block 1 
 
Start of Block: Block 2 
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Q43 RESEARCH PARTICIPANT INFORMATION SHEET      
TITLE: Changing Landscapes: Perspectives of Young African American women of 
Population-Wide Testing for Hereditary Breast Cancer Mutations     
  
VCU IRB NO.: HM20015881         
 
PRINCIPAL INVESTIGATOR:    Alesha Henderson, 
M.A.                                                          
                                                     Department of Health Behavior & Policy     
                                             Virginia Commonwealth University  
                                                     Phone: 804-614-8304                                                               
Email:Hendersonan2@mymail.vcu.edu                                        
                                                                                 
Maghboeba Mosavel, PhD 
Department of Health Behavior & Policy  
Virginia Commonwealth University 
Richmond, Virginia 23298-0149 
Phone: (804) 628-2929 
Fax: (804) 828-5440   
 
PURPOSE OF THE STUDY     
 
You are being invited to participate in this research study about population-wide testing 
for hereditary breast cancer mutations and your health communication preferences. The results of 
this study will be used to develop a survey that will be distributed to a larger sample of young 
African American women. In this study, you will be asked to complete a 15-minute online 
survey on the Qualtrics survey platform focusing on hereditary breast cancer mutations and 
potential population wide testing for hereditary breast cancer mutations. 
     
VOLUNTARY PARTICIPATION AND WITHDRAWAL      
 
Your participation in this research study is voluntary. You do not have to participate in this 
study. If you choose to participate, you may stop at any time without any penalty. You may also 
choose not to answer particular questions that are asked in the study. Discontinuing your 
participation or withdrawing from the study will not result in any loss or benefits to which you 
 
 
 
 
 
 
 
 
143 
are otherwise entitled.  If you decide to join the study, you may withdraw at any time and for any 
reason without penalty or loss of benefits.      
  
RISKS AND DISCOMFORTS     
 
There are minimal risks associated with participation in this study.  The questions asked in this 
study should not cause any distress. However, in the case that you feel that you need mental 
health services, Therapy for Black Girls is a great online resource to find local therapy services 
provided by African American women. There are also mobile apps, such as Betterhelp and 
Talkspace, that provide online therapy services.          
 
PAYMENT FOR PARTICIPATION     
 
You will be compensated the amount you agree upon before you entered into the survey.   
 
QUESTIONS     
 
If you have any questions, concerns, or complaints about this study now or in the future, please 
contact Alesha Henderson at 804-614-8304 or email her at hendersonan2@mymail.vcu.edu. She 
is currently a doctoral candidate in the Department of Health Behavior and Policy at Virginia 
Commonwealth University. 
 
End of Block: Block 2 
 
Start of Block: Default Question Block 
 
Q1 Survey Introduction: I am currently conducting research on the perspectives of young 
African American women between the ages of 18 and 30 on hereditary breast cancer mutations 
and the potential for population-wide testing for hereditary breast cancer mutations for all 
women in the United States among young women like yourselves. Questions will focus on your 
knowledge of and perspectives towards hereditary breast cancer mutations, potential population-
wide testing for hereditary breast cancer mutations, and your health communication preferences 
for messages about population-wide testing. This survey should take approximately 15 minutes 
to complete. If you have any questions about the survey, please email Alesha Henderson at 
hendersonan2@vcu.edu.    
 
 
 
Q2 Direct To Consumer Testing: Direct-to-consumer genetic tests are marketed directly to 
customers via television, print advertisements, or the Internet, and the tests can be bought online 
 
 
 
 
 
 
 
 
144 
or in stores. Customers send the company a DNA sample and receive their results directly from a 
secure website or in a written report. Direct-to-consumer genetic testing provides people access 
to their genetic information without necessarily involving a healthcare provider or health 
insurance company in the process. 
 
 
 
 
Q3 1.     Do you know or have you heard of genetic tests that are provided directly to consumers 
via the internet?  
o Yes (1)  
o No (2)  
 
 
 
 
Q4 2.     Have you ever done a genetic test which is provided directly to consumers via the 
internet?  
o Yes (1)  
o No (2)  
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Q5 Below are several statements describing why some people may do direct to consumer 
genetic testing. Please indicate how much you agree with each statement. For what 
reason/motivation would you do direct to consumer genetic testing? 
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 Strongly disagree (1) disagree (2) 
Neither agree 
nor disagree (3) agree (4) 
Strongly agree 
(5) 
3. To know 
more about my 
health. (1)  o  o  o  o  o  
4. So that the 
doctor can 
monitor my 
health. (2)  
o  o  o  o  o  
5.To change my 
lifestyle (e.g. 
dietary habits, 
exercise) in 
case the genetic 
test shows that I 
have an 
increased risk 
for a certain 
disease. (3)  
o  o  o  o  o  
6. To inform 
my children 
about their 
possible 
increased risk 
for a disease. 
(4)  
o  o  o  o  o  
7.Out of 
curiosity. (5)  o  o  o  o  o  
8. Out of 
scientific/ 
research interest 
(6)  
o  o  o  o  o  
9.  For fun. (7)  o  o  o  o  o  
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Q6 Below are several statements describing why some people may not do direct to consumer 
genetic testing. Please indicate how much you agree with each statement. For what reason 
would you not like to do direct to consumer genetic testing?  
 Strongly disagree (1) disagree (2) 
Neither agree 
nor disagree 
(3) 
agree (4) Strongly agree (5) 
10. The results 
are unreliable. 
(1)  o  o  o  o  o  
11. The 
information 
will not be 
useful. (2)  
o  o  o  o  o  
12. I wouldn’t 
like to know 
the risk I have 
to develop a 
certain disease. 
(3)  
o  o  o  o  o  
13.  I 
worry about 
my personal 
data and 
private life. (4)  
o  o  o  o  o  
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Q7 The next set of questions is to find out how much you may already know about genes 
for cancer.  
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 True (1) False (2) 
14. 50% (or half) of 
inherited genetic information 
(about breast cancer risk) is 
passed down from a person’s 
mother. (1)  
o  o  
15. 25% of inherited genetic 
information (about breast cancer 
risk) is passed down from a 
person’s father. (2)  
o  o  
16. There is more than one gene 
that can increase the risk of 
breast cancer (3)  o  o  
17. A woman who has a sister 
with a breast cancer gene 
mutation has a 1 in 4 chance of 
having a gene mutation herself. 
(4)  
o  o  
18. One in ten women has a 
breast cancer gene mutation (5)  o  o  
19. Women who test 
positive for breast cancer gene 
mutations are more likely to 
develop breast cancer at a young 
age. (6)  
o  o  
20. If a woman tests 
positive for a breast cancer gene 
mutation, her male relatives’ 
risk for developing prostate 
cancer are lowered (7)  
o  o  
21. A woman may be at a 
greater risk for developing 
ovarian cancer if she has several 
close relatives with breast 
cancer (8)  
o  o  
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22. A woman who has her 
healthy ovaries removed will 
definitely not get ovarian cancer 
(9)  
o  o  
23. A woman who has her 
breasts removed will definitely 
not get breast cancer (10)  o  o  
24. Screening for ovarian cancer 
often does not detect a tumor 
until it’s more advanced. (11)  o  o  
 
 
 
 
Q8 Genetic Counseling:  Genetic counseling is a communication process between a specially 
trained health professional and a person concerned about the genetic risk of disease. The person's 
family and personal medical history may be discussed, and counseling may lead to genetic 
testing.  
 
 
 
 
Q9 25.    Have you ever heard about genetic counseling for hereditary breast cancer genes 
(e.g.,BRCA)?  
o Yes (1)  
o No (2)  
 
Skip To: Q11 If 25.    Have you ever heard about genetic counseling for hereditary breast cancer genes 
(e.g.,BRCA... = No 
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Q10 26.   If yes, how did you hear about genetic counseling for hereditary breast cancer genes 
(e.g.,  BRCA1 and BRCA2)? Please check all that apply:  
▢ TV (1)  
▢ Newspaper (2)  
▢ Internet (3)  
▢ Friends (4)  
▢ Family (5)  
▢ Physician (6)  
▢ Other Health Profession: Please Specify (7) 
________________________________________________ 
 
 
 
 
Q11 27.   Has your healthcare provider ever talked to you about genetic counseling for hereditary 
breast cancer mutations?  
o Yes (1)  
o No (2)  
 
Skip To: Q13 If 27.   Has your healthcare provider ever talked to you about genetic counseling for hereditary bre... 
= No 
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Q12 28. Did she/he give you a referral for genetic counseling?  
o Yes (1)  
o No (2)  
 
 
 
Q13 Genetic Testing: Genetic testing for hereditary breast cancer looks for a mutation in your 
genes.  
 
 
 
 
Q14 29. Have you ever heard about genetic testing for hereditary breast cancer genes 
(e.g. BRCA)? 
o Yes (1)  
o No (2)  
 
Skip To: Q17 If 29. Have you ever heard about genetic testing for hereditary breast cancer genes (e.g. BRCA)? = 
No 
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Q15 30. If yes, how did you hear about genetic testing for hereditary breast cancer mutations. 
Please check all that apply:  
▢ TV (1)  
▢ Newspaper (2)  
▢ Internet (3)  
▢ Friends (4)  
▢ Family (5)  
▢ Physician (6)  
▢ Other Health profession: Please Specify (7) 
________________________________________________ 
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Q17 The next questions focus on your perspectives of hereditary breast cancer mutations.    
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 Strongly disagree (1) disagree (2) 
Neither agree 
nor disagree 
(3) 
agree (4) Strongly agree (5) 
31. If I were 
found to carry 
the gene, it 
would help 
members of 
my family like 
daughter(s) or 
sister(s) decide 
whether to 
undergo 
genetic testing. 
(1)  
o  o  o  o  o  
32.
 Knowi
ng that I carry 
the gene would 
help me decide 
whether to go 
for more 
frequent 
mammograms. 
(2)  
o  o  o  o  o  
33.  My 
concerns about 
developing 
breast cancer 
would be 
reduced if I 
knew I did not 
carry the gene. 
(5)  
o  o  o  o  o  
 
 
 
 
 
 
 
 
156 
34.  Knowing 
whether or not 
I carry the 
gene would 
increase my 
sense of 
personal 
control. (3)  
o  o  o  o  o  
35.  Knowing 
that I do not 
carry the gene 
would greatly 
improve my 
quality of life. 
(4)  
o  o  o  o  o  
36.  My 
concerns about 
developing 
breast cancer 
would increase 
if I knew that I 
carried the 
gene. (6)  
o  o  o  o  o  
37. If I were 
found to carry 
the gene, it 
would 
jeopardize my 
insurance 
coverage or 
lead to 
problems with 
my employers. 
(8)  
o  o  o  o  o  
38. If I were 
found to carry 
the gene, it 
would cause 
others to view 
me negatively. 
(9)  
o  o  o  o  o  
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39.  If I were 
found to carry 
the gene, it 
would lead to 
marital or 
family 
problems. (10)  
o  o  o  o  o  
40. Knowing 
that I do not 
carry the gene 
would not be 
helpful since I 
could still 
develop breast 
cancer. (7)  
o  o  o  o  o  
41. Testing is 
not worthwhile 
because it 
could yield 
inconclusive 
results about 
whether I carry 
the gene for 
breast cancer. 
(11)  
o  o  o  o  o  
42. If I were 
found to carry 
the gene for 
breast cancer, I 
would worry 
about passing 
the gene to my 
children. (12)  
o  o  o  o  o  
43. If I were 
found to carry 
the gene, I 
would worry 
that the results 
would not stay 
confidential. 
(13)  
o  o  o  o  o  
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Q18    44. How likely do you think it is that you carry a hereditary breast cancer mutation?  
o Not at all likely (1)  
o Somewhat Likely (2)  
o Likely (3)  
o Very Likely (4)  
o Extremely Likely (5)  
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Q19 The next set of questions ask you to imagine the reaction you would have if you were to 
be told you have a hereditary breast cancer mutation.  
 Strongly disagree (1) disagree (2) 
Neither agree 
nor disagree 
(3) 
agree (4) Strongly agree (5) 
45. If I 
found out I 
carried a gene 
mutation, it 
would greatly 
disrupt my life. 
(1)  
o  o  o  o  o  
46.
 Findin
g out I carried 
a gene 
mutation 
would be very 
difficult for 
me. (2)  
o  o  o  o  o  
47. If I found 
out I carried a 
gene mutation, 
I would worry 
much more 
about 
developing 
breast cancer. 
(3)  
o  o  o  o  o  
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Q20 When getting health care, have you ever had the following things happen to you 
because of your race or ethnicity? 
 Yes (1) No (2) 
48.  Been treated with less 
courtesy than other people. (1)  o  o  
49.  Been treated with less 
respect than other people. (2)  o  o  
50.  Received poorer 
service than others. (3)  o  o  
51. Had a doctor or nurse act as 
if he or she thinks you are not 
smart? (4)  o  o  
52. Had a doctor or nurse act as 
if he or she is afraid of you? (5)  o  o  
53. Had a doctor or nurse act as 
if he or she is better than you? 
(6)  o  o  
54. Felt like a doctor or nurse 
was not listening to what you 
were saying? (7)  o  o  
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Q21 Thinking about various racial/ethnic groups and their interaction with the American 
medical system, please rate how strongly you agree or disagree with the following 
statements.  Please note, we are referring to your general feelings… 
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 Strongly disagree (1) disagree (2) Neutral (3) Agree (4) 
Strongly 
Agree (5) 
55.Doctors and 
health care 
workers 
sometimes 
hide 
information 
from patients 
who belong to 
my 
racial/ethnic 
group (1)  
o  o  o  o  o  
56.Doctors 
have the best 
interests of 
people of my 
racial/ethnic 
group in mind 
(2)  
o  o  o  o  o  
57.People of 
my 
racial/ethnic 
group should 
not confide in 
doctors and 
health care 
workers 
because it will 
be used against 
them (3)  
o  o  o  o  o  
58.People of 
my 
racial/ethnic 
group should 
be suspicious 
(distrustful) of 
information 
from doctors 
and health care 
workers (4)  
o  o  o  o  o  
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59.People of 
my 
racial/ethnic 
group cannot 
trust doctors 
and health care 
workers (5)  
o  o  o  o  o  
60. People 
of my 
racial/ethnic 
group should 
be suspicious 
of modern 
medicine (6)  
o  o  o  o  o  
61.
 Doctor
s and health 
care workers 
treat people of 
my 
racial/ethnic 
group like 
“guinea pigs” 
(7)  
o  o  o  o  o  
62. People 
of my 
racial/ethnic 
group receive 
the same 
medical care 
from doctors 
and health care 
workers as 
people from 
other groups 
(8)  
o  o  o  o  o  
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63.Doctors and 
health care 
workers do not 
take the 
medical 
complaints of 
people of my 
racial/ethnic 
group 
seriously (9)  
o  o  o  o  o  
64. People 
of my 
racial/ethnic 
group are 
treated the 
same as people 
from other 
groups (10)  
o  o  o  o  o  
65. In 
most hospitals, 
people of 
different 
racial/ethnic 
groups receive 
the same kind 
of care (11)  
o  o  o  o  o  
66. I have 
personally 
been treated 
poorly or 
unfairly by 
doctors or 
health care 
workers 
because of my 
racial/ethnic 
group. (12)  
o  o  o  o  o  
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Q22    The next questions ask about the ways you may or may not have relied on religion to 
deal with life stressors.    
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 Not at all (1) Very Little (2) Somewhat (3) A Great deal (4) 
67. Looked 
for a stronger 
connection with 
God. (1)  
o  o  o  o  
68. Sought 
God’s love and 
care. (2)  o  o  o  o  
69. Sought 
help from God in 
letting go of my 
anger. (3)  
o  o  o  o  
70. Tried to 
put my plans into 
action together 
with God. (4)  
o  o  o  o  
71. Tried to 
see how God was 
trying to 
strengthen me in 
this situation. (5)  
o  o  o  o  
72. Asked 
forgiveness for my 
sins. (6)  o  o  o  o  
73. Focused 
on religion to stop 
worrying about 
my problems. (7)  
o  o  o  o  
74. Wondered 
whether God had 
abandoned me. (8)  o  o  o  o  
75. Felt 
punished by God 
for my lack of 
devotion. (9)  
o  o  o  o  
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76.
 Questione
d God’s love for 
me. (10)  
o  o  o  o  
77. Wondered 
whether my 
church had 
abandoned me. 
(11)  
o  o  o  o  
78. Decided 
the devil made this 
happen to me. (12)  o  o  o  o  
79. Questioned the 
power of God. 
(13)  o  o  o  o  
 
 
 
 
Q23 Population-based testing for hereditary breast cancer mutations:  There is a current 
proposal to offer genetic counseling and testing for hereditary breast cancer mutations to all 
women in the United States starting at age 30. Please answer the next questions with this in 
mind.     
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Q24 80.  Now try to imagine that you are offered genetic testing and counseling for breast cancer 
susceptibility through a population-based testing initiativeat some point in the future, would you 
choose to have the test 
o No, Definitely not (1)  
o Not, Probably not (2)  
o Unsure (3)  
o Yes, probably (4)  
o Yes, definitely (5)  
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Q25 The next questions ask you to imagine what people close to you would think of you 
participating in population-based testing if it becomes available. 
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 Strongly Disagree (1) Disagree (2) 
Neither Agree/ 
Disagree (3) Agree (4) 
Strongly 
Agree (5) 
81. My friends 
would approve 
of me getting 
genetic testing 
and counseling 
through 
population-
based testing. 
(1)  
o  o  o  o  o  
82. My 
spouse would 
approve of me 
getting genetic 
testing and 
counseling 
through 
population-
based testing. 
(2)  
o  o  o  o  o  
83. My 
parents would 
approve of me 
getting genetic 
testing and 
counseling 
through 
population-
based testing. 
(3)  
o  o  o  o  o  
84. My 
siblings would 
approve of me 
getting genetic 
testing and 
counseling 
through 
population-
based testing. 
(4)  
o  o  o  o  o  
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85. My 
other family 
member would 
approve of me 
getting genetic 
testing and 
counseling 
through 
population-
based testing. 
(5)  
o  o  o  o  o  
 
 
 
 
 
Q26 86.  Would you be willing to pay out of pocket for genetic testing for breast cancer risk 
through population-wide testing?  
o Up to $50 (1)  
o Up to $100 (2)  
o Up to $200 (3)  
o Up to $500 (4)  
o More than $500 (5)  
o I would not be willing to pay any money (6)  
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Q27 87.   Imagine you had a strong need to get information about population-based testing for 
hereditary breast cancer mutations. Where would you go first to get information? (Mark only 
one) 
o Printed materials (for example, newspapers, magazines) (1)  
o Health care provider (doctor, nurse, social worker) (2)  
o Conversations with people you trust (friends, relatives, or co-workers) (3)  
o Internet (Google or another search engine, WebMD or another medical website) (4)  
o Social Media (Facebook, Instagram, Twitter) (5)  
 
 
 
 
Q28 88.   Imagine you had a strong need to get information about population-based testing for 
hereditary breast cancer mutations. Which of the following would you most trust as a source of 
information about population-based testing for hereditary breast cancer mutations? (Mark only 
one)  
o Printed materials (for example, newspapers, magazines) (1)  
o Health care provider (doctor, nurse, social worker) (2)  
o Conversations with people you trust (friends, relatives, or co-workers) (3)  
o Internet (Google or another search engine, WebMD or another medical website) (4)  
o Social Media (Facebook, Instagram, Twitter) (5)  
 
 
 
Q29 Thanks for completing the survey. The next questions ask you to provide demographic 
information about yourself.    
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Q31 1. Do you have a family history of breast cancer? 
o Yes (1)  
o No (2)  
 
 
 
 
Q32 2.   Are you Hispanic or Latino?  
o Yes, Hispanic or Latino (1)  
o Not, Hispanic or Latino (2)  
 
 
 
 
Q34 3. What is your highest grade or level of schooling you have completed?  
o Less than high school (1)  
o High school graduate (2)  
o Some college or technical degree (3)  
o Bachelor's degree (4)  
o Graduate degree (5)  
 
 
 
 
 
 
 
 
 
 
 
 
175 
Q35 4.     Do you have health insurance?  
o Yes (1)  
o No (2)  
o Not sure (3)  
 
 
 
 
Q36 5.  Do you have a regular physician or health care provider?  
o Yes (1)  
o No (2)  
 
 
 
 
Q37 6. What is your income?  
o Less than $20,000 (1)  
o $20,000-$39,999 (2)  
o $40,000- $59,999 (3)  
o $60,000- $79,999 (4)  
o $80,000- $99,999 (5)  
o $100,000- $119,999 (6)  
o At least $120,000 (7)  
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Q38 7.   What is your employment status?  
o Full-time  (1)  
o Part-time  (2)  
o Unemployed  (3)  
o Retired  (4)  
o Unable to work  (5)  
o Homemaker  (6)  
o Student  (7)  
 
 
 
 
Q39 8. What is your marital status?  
o Married  (1)  
o Living Together  (2)  
o Divorced  (3)  
o Widowed  (4)  
o Separated  (5)  
o Never Married  (6)  
 
End of Block: Default Question Block 
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